<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Psychiatry</journal-id>
<journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Frontiers in Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-0640</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28878696</article-id>
<article-id pub-id-type="pmc">5572414</article-id>
<article-id pub-id-type="doi">10.3389/fpsyt.2017.00153</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>“I Am I and My Bacterial Circumstances”: Linking Gut Microbiome, Neurodevelopment, and Depression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lima-Ojeda</surname>
<given-names>Juan M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
<uri xlink:href="http://frontiersin.org/people/u/414295" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rupprecht</surname>
<given-names>Rainer</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/39311" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baghai</surname>
<given-names>Thomas C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/371382" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Psychiatry and Psychotherapy, University of Regensburg</institution>, <addr-line>Regensburg</addr-line>, <country>Germany</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Stefan Borgwardt, University of Basel, Switzerland</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Serge Brand, University of Basel, Switzerland; Sergueï O. Fetissov, University of Rouen, France; Michael Deuschle, Central Institute of Mental Health, Germany</p>
</fn>
<corresp content-type="corresp" id="cor1">*Correspondence: Juan M. Lima-Ojeda, <email>juan.lima-ojeda@medbo.de</email></corresp>
<fn fn-type="other" id="fn002">
<p>Specialty section: This article was submitted to Psychosomatic Medicine, a section of the journal Frontiers in Psychiatry</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>153</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>8</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Lima-Ojeda, Rupprecht and Baghai.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Lima-Ojeda, Rupprecht and Baghai</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Recently, there has been renewed interest in the role played by microbiome in both human health and human disease. A correct equilibrium between the human host and their microorganisms is important for an appropriate physiological function. Extensive research has shown that microbes that inhabit the gastrointestinal tract—or gut microbiota—are involved not only in both nutritive and digestive activities but also in immunological processes. Moreover, the gut microbiome influences both central nervous system and energy homeostasis. An altered gut microbiome has been associated with the pathophysiology of different diseases, including neuropsychiatric disorders. Apparently, both environmental—diet, exposition to antibiotics, and infections—and host-genetic factors have a strong influence on gut microbiome, modulating the risk for neuropsychiatric illness. Also, early life disruption of the microbiome–gut–brain (MGB) axis has been associated with an increased risk of developing depression later in life, suggesting a link between gut microbiome, neurodevelopment, and depression. This review aims to contribute to this growing area of research by exploring the role played by the gut microbiome in neurodevelopment and in the etiology of the depressive syndrome, including nutritional, immunological, and energy homeostasis approaches.</p>
</abstract>
<kwd-group>
<kwd>gut microbiome</kwd>
<kwd>neurodevelopment</kwd>
<kwd>depression</kwd>
<kwd>neuroimmune–endocrine system</kwd>
<kwd>microbiome–gut–brain axis</kwd>
<kwd>hypothalamic–pituitary–adrenal axis</kwd>
<kwd>energy homeostasis</kwd>
<kwd>nutrition</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn01">Bundesministerium für Bildung und Forschung<named-content content-type="fundref-id">10.13039/501100002347</named-content></funding-source>
<award-id rid="cn01">01EE1401B</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="122"></ref-count>
<page-count count="13"></page-count>
<word-count count="11817"></word-count>
</counts>
</article-meta>
</front>
<body>
<p>The title of this review is a paraphrase of the maxim from Ortega y Gasset: <italic>Yo soy yo y mi circunstancia, y si no la salvo a ella no me salvo yo</italic> (“I am I and my circumstance; and, if I do not save it, I do not save myself”) (<xref ref-type="bibr" rid="B1">1</xref>).</p>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p>Our world has an extraordinary diversity of life forms. A key aspect of them is their individuality; each creature on Earth—unicellular or multicellular—has its own characteristics. So, on our planet, it is possible to identify, in different ecosystems (Table <xref ref-type="table" rid="T1">1</xref>), numerous animals, bacteria, plants, fungi, and archaea. Each creature plays an important and unique role in its habitat. On Earth, there are several ecosystems and all of them are characterized by complex interactions between different organisms.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Brief glossary.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Glossary</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Anaerobic bacteria</bold>: microorganisms that have the characteristic that they are able to growth without oxygen</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Anorexigenic cells</bold>: cells associated with the loss of appetite</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Binary fission</italic>: in bacteria, it is an asexual reproduction where the bacterium duplicates its deoxyribonucleic acid, generating a new daughter cell—or more than one daughter cell—with the same characteristics that the mother or original bacterium</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dysbiosis</bold>: term employed to refer to important disruptions at the indigenous bacterial level, including both structural and compositional alterations</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Ecosystem</bold>: a complex system where living creatures interact with their environment and its physical components, being all its constituent interconnected elements</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Germ-free (GF) mice</bold>: GF mice are animals without microorganisms’ colonization in or on their bodies</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gnotobiotic</bold>: it refers to an environment where all its microorganisms are controlled or known</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gut-brain axis</bold>: a complex network characterized for a strong connection between the gastrointestinal tract and the central nervous system (CNS). It is a bidirectional system</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Immunosenescence</bold>: age-related chronic and progressive process at the immune level that is associated with an increased pro-inflammatory activity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Inflamm-aging</bold>: an increased inflammatory response associated with the development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Lactic acid bacteria</bold>: microorganisms that produce lactic acid</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Meconium</bold>: earliest feces from infants</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Microbiome</bold>: term employed to refer to the combination of microorganisms and their genetic materials. Sometimes this term is used in the scientific literature as synonym of microbiota</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Microbiome-gut-brain (MGB) axis</bold>: bidirectional connection between the gastrointestinal tract and the CNS, including the gastrointestinal microbiome. Frequently this term is used as synonym of microbiota–gut–brain axis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Microbiota</bold>: microorganisms that inhabit a particular environment, e.g., a specific anatomical region</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Microbiota-gut-brain (MGB) axis</bold>: a bidirectional axis that communicates the intestinal microbiota with the brain</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Minor physical anomalies</bold>: congenital physical changes associated with insults during the development</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Orexigenic cells</bold>: cells that are associated with the induction of appetite</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Polyphenols</bold>: compounds of chemical kind that are produced by plants</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Prebiotics</bold>: kind of dietary fibers that are beneficial for both microbiota development and function</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Probiotics</bold>: term used to refer to living microorganisms which ingestion has been associated with host’s benefits at the health level</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Xenobiotics</bold>: foreign substances that are founded in the environment and that are usually synthetic chemicals</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Microorganisms such as bacteria are important for the human life. Some products are obtained because of fermentation (<xref ref-type="bibr" rid="B2">2</xref>), including bread, beer, wine, cheese, and yogurt (<xref ref-type="bibr" rid="B2">2</xref>). In general, bacteria have influence not only in our eating culture (<xref ref-type="bibr" rid="B3">3</xref>) but also in different sociocultural and economical aspects of human life (<xref ref-type="bibr" rid="B3">3</xref>). Microbiome (Table <xref ref-type="table" rid="T1">1</xref>) in and on human bodies is a dominant feature of our individuality (<xref ref-type="bibr" rid="B3">3</xref>), increasing the number of publications about microbiome–human bodies interactions (<xref ref-type="bibr" rid="B3">3</xref>). In general, host–microbiota (Table <xref ref-type="table" rid="T1">1</xref>) ecosystem is a story of cooperation (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>), reflecting past and present of both host and their microorganisms (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). In order to avoid any confusion, in this paper, we will use the term “microbiome” to refer to both the microbes and their genetic materials, as unit, and not as synonym of the term “microbiota.” Also, for the purpose of this manuscript, we will focus on gastrointestinal bacterial microbiome.</p>
<p>There are differences in the microbiome composition among vertebrates (<xref ref-type="bibr" rid="B6">6</xref>). Also, individuals from the same species show some variations in their microbiome (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B6">6</xref>). Each anatomical region has its microbiome (<xref ref-type="bibr" rid="B6">6</xref>), which has its own characteristics (<xref ref-type="bibr" rid="B6">6</xref>). The gastrointestinal tract in humans is a sanctuary of living organisms, the most of our microbiota inhabit this region (<xref ref-type="bibr" rid="B7">7</xref>). It has been pointed out that if we are born sterile, bacteria that inhabit our gastrointestinal tract may come from the external environment—outside the boundaries of our bodies—(<xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>Gastrointestinal microorganisms proliferate by binary fission (Table <xref ref-type="table" rid="T1">1</xref>) (<xref ref-type="bibr" rid="B4">4</xref>). This ecosystem is a dynamic one (<xref ref-type="bibr" rid="B4">4</xref>), where changes at the level of the microbiota composition have been associated with physiological dysfunction and health alterations (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). Recently, there has been renewed interest in the role played by microbiome in the neuropsychiatric sphere (<xref ref-type="bibr" rid="B10">10</xref>). It has been noted that gastrointestinal bacteria have influence on behavioral and cognitive processes (<xref ref-type="bibr" rid="B11">11</xref>). Moreover, there is a growing body of literature that recognizes the importance of gut microbiome in neurodevelopment (<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>If we want to understand our individuality, we should accept the importance of the innumerable creatures that are around us and to understand the interactions between the different individuals that are part of the numerous ecosystems on Earth. In general, the world that surrounds us is important to define our individuality. This situation is better expressed by the famous maxim of the illustrious philosophe José Ortega y Gasset, a well-known intellectual who wrote at the beginning of the twentieth century: <italic>Yo soy yo y mi circunstancia, y si no la salvo a ella no me salvo yo</italic> (“I am I and my circumstance; and, if I do not save it, I do not save myself”) (<xref ref-type="bibr" rid="B1">1</xref>). The main goal of this review is to explore the relationship between gut microbiome, neurodevelopment, and depression. Also nutritional, immunological and energy homeostasis approaches with relevance in the neurobiology of the depressive syndrome are explored. We conducted an English language literature search using the biomedical database PubMed. To improve the quality of our manuscript, we included complementary information.</p>
</sec>
<sec id="S2">
<title>Microbes in Human Health and in Human Disease: A Story of Co-Evolution</title>
<p>For centuries, humans and bacteria have evolved together (<xref ref-type="bibr" rid="B8">8</xref>). We have a strong interaction with our indigenous microbiota (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B13">13</xref>). From a gnotobiotic (Table <xref ref-type="table" rid="T1">1</xref>) condition during the intrauterine life to a complex microbiome–human interaction with a begin at birth (<xref ref-type="bibr" rid="B8">8</xref>), bacteria in and on human bodies are influenced by both environmental and host-genetic factors (<xref ref-type="bibr" rid="B8">8</xref>). The constitution of microorganisms that inhabit our organism is defined by host-genetic material (<xref ref-type="bibr" rid="B9">9</xref>). Evidence suggests that microbiome is able to mediate host gene expression (<xref ref-type="bibr" rid="B11">11</xref>). Surprisingly, most of the cells in and on human body are microorganisms or microbes (<xref ref-type="bibr" rid="B14">14</xref>). Also, microorganisms in humans have complex genomes. For example, the gastrointestinal microbiome has a genome that is around 100 times more numerous than human’s one (<xref ref-type="bibr" rid="B15">15</xref>), being the products of a large number of these microorganism genes significantly important for the physiology of the host (<xref ref-type="bibr" rid="B16">16</xref>). Using deoxyribonucleic acid (DNA) extraction from a European human fecal sample collection with 124 individuals it has been characterized the human gut microbiome (<xref ref-type="bibr" rid="B17">17</xref>), which has 3.3 million genes (<xref ref-type="bibr" rid="B17">17</xref>), being the most of them from bacteria—99.1% (<xref ref-type="bibr" rid="B17">17</xref>). Interestingly, bacteria have the ability to obtain genes that they need to continue to live (<xref ref-type="bibr" rid="B4">4</xref>). Since microorganisms that cohabit within the same environment are able to swap genes (<xref ref-type="bibr" rid="B4">4</xref>), the dominant bacterial population gain control over processes of swapping genetic material (<xref ref-type="bibr" rid="B4">4</xref>). Also, inheritance of the microbiota has been suggested (<xref ref-type="bibr" rid="B6">6</xref>), particularly this one associated with the mother (<xref ref-type="bibr" rid="B6">6</xref>), which is a stable vertical inheritance (<xref ref-type="bibr" rid="B4">4</xref>). It has been proposed that if we wish to have a better knowledge about ourselves, we should look at our genome, including our indigenous bacterial genome (<xref ref-type="bibr" rid="B13">13</xref>). In general, humans and their indigenous microbiota have co-evolved together, establishing a dynamic ecosystem.</p>
<p>There is evidence about interactions between animal hosts and their microbiome (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B18">18</xref>–<xref ref-type="bibr" rid="B20">20</xref>). Environmental factors, such as diet (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>), infections (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B9">9</xref>), and antibiotics (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B18">18</xref>), may alter these interactions (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Early in development, the acquisition of bacteria in body structures such as the gastrointestinal tract is important to develop an adequate tolerance to antigens (<xref ref-type="bibr" rid="B13">13</xref>). Moreover, it has been suggested that indigenous microbiome is important for an appropriate host development during extrauterine life (<xref ref-type="bibr" rid="B13">13</xref>). The growth of microorganisms in the host’s gastrointestinal tract depends also of both gut physical—intestinal movements (<xref ref-type="bibr" rid="B19">19</xref>)—and chemical—both digestive enzymes and acid secretions (<xref ref-type="bibr" rid="B19">19</xref>), oxygen quantity (<xref ref-type="bibr" rid="B21">21</xref>), pH (potential of hydrogen) level (<xref ref-type="bibr" rid="B21">21</xref>)—factors (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B21">21</xref>). It has been proposed that our daily intake modulates gut microbiome (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B22">22</xref>), being carbohydrates an important source of nutrients for gut bacteria (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B18">18</xref>). Since gut microorganisms require nutrients for their development (<xref ref-type="bibr" rid="B19">19</xref>) and the bacteria’s host is the most important supplier of nutrients for them (<xref ref-type="bibr" rid="B19">19</xref>), then host’s feelings such as satiety and hunger are important factors defining gut bacterial composition (<xref ref-type="bibr" rid="B19">19</xref>). In general, host–microbiota interaction is an important factor modulating bacterial energy homeostasis at the gut level (<xref ref-type="bibr" rid="B19">19</xref>). A hypothesis from the second half of the twentieth century pointed out that the composition of the indigenous organisms that inhabit the gastrointestinal tract is limited by the effective management of nutrients between species of bacteria (<xref ref-type="bibr" rid="B23">23</xref>). More recently, it has been noted that the inclusion of vegetables, whole grains, fish, and fruits in our diet is positive for our gastrointestinal microbiome (<xref ref-type="bibr" rid="B22">22</xref>). Intake of omega-3 fatty acids, folic acid, S-adenosyl-methionine, <sc>l</sc>-tryptophan, vitamin B<sub>12</sub>, and vitamin D has been associated with a mental health improvement (<xref ref-type="bibr" rid="B22">22</xref>). Interestingly, dietary interventions, including supplements of minerals, essential fatty acids (EFAs) and vitamins, have been associated with a better behavior in humans (<xref ref-type="bibr" rid="B24">24</xref>). For example, results from a double blind, placebo-controlled, randomized study with adult prisoners showed that a nutritional supplementation of EFAs, minerals, and vitamins was associated with an antisocial behavior improvement (<xref ref-type="bibr" rid="B24">24</xref>).</p>
<p>One of the most significant findings to emerge from different studies about human microbiome is that perturbations of the host–microbiota are associated with an increased risk for different diseases (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B25">25</xref>), including gastrointestinal diseases (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B25">25</xref>), dermatological illness (<xref ref-type="bibr" rid="B6">6</xref>), obesity (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B25">25</xref>), type 1 diabetes (<xref ref-type="bibr" rid="B25">25</xref>), neurodegenerative illness (<xref ref-type="bibr" rid="B26">26</xref>), neuropsychiatric diseases (<xref ref-type="bibr" rid="B10">10</xref>), neuroimmune diseases (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>), and rheumatic disorders (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B25">25</xref>), where changes in the interactions between microbiome and host immune system have been proposed as important etiological factors (<xref ref-type="bibr" rid="B6">6</xref>). Sometimes our immune system is unsuccessful in restricting our indigenous microbiota (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B13">13</xref>), then the microorganisms are not more positive at all. Microbes are considered pathogens when they are able to produce a disease (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Despite the importance of microbiota–human host cooperation, there remains a paucity of knowledge on microbes–human host equilibrium. The Nash equilibrium—a concept from the game theory (<xref ref-type="bibr" rid="B8">8</xref>)—has been used to try to explain “the rule” of this cooperation (<xref ref-type="bibr" rid="B8">8</xref>). According to this concept, the players—or both indigenous bacteria and human body—know the rules of the game—or equilibrium—(<xref ref-type="bibr" rid="B8">8</xref>). When one of the players departs from the established rules, this player will be sanctioned—maybe by host immunity—, taking a weak position (<xref ref-type="bibr" rid="B8">8</xref>). However, biological interactions, such as this one observed between microorganisms and human body, are “more dynamic and complex games” to be clarified under this theory.</p>
<p>The microorganisms that inhabit the gastrointestinal tract, including their genome are known as gut microbiome (<xref ref-type="bibr" rid="B25">25</xref>). A significant number of microorganisms—10 trillion (<xref ref-type="bibr" rid="B9">9</xref>) to 100 trillion (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B15">15</xref>–<xref ref-type="bibr" rid="B17">17</xref>)—is part of the adult gut (<xref ref-type="bibr" rid="B15">15</xref>). The most of them are anaerobic bacteria (Table <xref ref-type="table" rid="T1">1</xref>)—99.9% (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B20">20</xref>)—and inhabit the distal part of the gastrointestinal tract (<xref ref-type="bibr" rid="B15">15</xref>). The gastrointestinal tract is entirely inhabited by microorganisms (<xref ref-type="bibr" rid="B21">21</xref>), in ascendant quantity from the duodenum to the last part of the colon (<xref ref-type="bibr" rid="B21">21</xref>). There is an important presence of cytophaga–flavobacterium–bacteroides (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B28">28</xref>) and Firmicutes (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B28">28</xref>). Other examples of dominant habitants of the gastrointestinal tract are: <italic>Streptococcus</italic> in the distal esophagus and <italic>Helicobacter</italic> in the gastric region (<xref ref-type="bibr" rid="B18">18</xref>). In general, the gut flora has subjects from <italic>Firmicutes, Bacteroidetes, Verrucomicrobia, Actinobacteria, Proteobacteria</italic>, and <italic>Fusobacteria</italic> phyla (<xref ref-type="bibr" rid="B29">29</xref>), being the most of the intestinal microorganisms part of the first two phyla (<xref ref-type="bibr" rid="B29">29</xref>). Normally, the gut offers a stable environment to these bacteria (<xref ref-type="bibr" rid="B11">11</xref>). These microorganisms are able to communicate with each other (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B15">15</xref>) and they have a strong connection with the host’s organism (<xref ref-type="bibr" rid="B15">15</xref>). Gut microorganisms are dynamic inhabitants of the gastrointestinal tract (<xref ref-type="bibr" rid="B19">19</xref>), processes of growing, lysis, and elimination are part of the mechanisms that stabilize the bacterial population (<xref ref-type="bibr" rid="B19">19</xref>). In general, gut microbiome is beneficial for the human host (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B25">25</xref>); these microorganisms are involved with digestive and nutritive processes (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B25">25</xref>). For example, gut bacteria are related to the metabolism of lipids, proteins, carbohydrates, and vitamins such as B and K (<xref ref-type="bibr" rid="B18">18</xref>). Interestingly, there is evidence that gastrointestinal microorganisms play a crucial role in metabolizing medicaments and xenobiotic substances (Table <xref ref-type="table" rid="T1">1</xref>) (<xref ref-type="bibr" rid="B18">18</xref>). Also, the gut microbiome reinforces host immunity (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B25">25</xref>) and influences the formation of gut vasculature (<xref ref-type="bibr" rid="B20">20</xref>). In the intestine, gut microbiome modulates both adaptive and innate immunity (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B25">25</xref>). For an adequate gastrointestinal epithelium, the gut microbiome is important (<xref ref-type="bibr" rid="B27">27</xref>). At the gastrointestinal level, bacteria are involved in the presence of a “physiological inflammation” (<xref ref-type="bibr" rid="B11">11</xref>), which is important for a gut in good health (<xref ref-type="bibr" rid="B11">11</xref>). However, gut microbiome dysbiosis (Table <xref ref-type="table" rid="T1">1</xref>)—or important changes at the level of the structure and the composition of the microorganisms (<xref ref-type="bibr" rid="B9">9</xref>)—has been linked with pathological autoimmune processes in the nervous system (<xref ref-type="bibr" rid="B27">27</xref>).</p>
<p>It is important to note that it has been suggested that the first 36 months of extrauterine life are fundamental defining host–bacterial composition (<xref ref-type="bibr" rid="B28">28</xref>) and that the sequence of the bacterial transition during the first months of life is difficult to define (<xref ref-type="bibr" rid="B30">30</xref>). Environmental factors, including vaginal delivery and breast milk (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B28">28</xref>), influence strongly early exposition to bacterial communities in humans (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B28">28</xref>), especially to lactic acid bacteria (Table <xref ref-type="table" rid="T1">1</xref>) (<xref ref-type="bibr" rid="B6">6</xref>). Also, environmental factors are able to alter the gut microbiome equilibrium (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Some other environmental factors that have been reported as elements that could influence gut microbiome characteristics are factors, such as prebiotics and probiotics (Table <xref ref-type="table" rid="T1">1</xref>) consumption, family composition, cultural practices, locality, antibiotics, and mother–infant interactions (<xref ref-type="bibr" rid="B30">30</xref>). Together, these data indicate that microbiome–human interaction is a story of diversity and adaptability (<xref ref-type="bibr" rid="B15">15</xref>). However, the whole association between microbiome and different diseases is still unknown (<xref ref-type="bibr" rid="B6">6</xref>).</p>
<sec id="S2-1">
<title>The Gut Microbiome and the Nervous System: The Microbiome–Gut–Brain Axis</title>
<p>The gut–brain (GB) axis (Table <xref ref-type="table" rid="T1">1</xref>) is a complex system that integrates the gut with the nervous system (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B16">16</xref>). A main characteristic of this system is its bidirectionality (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B31">31</xref>), where a neuro-endocrino-immunological connection is implicated (<xref ref-type="bibr" rid="B16">16</xref>) (Figure <xref ref-type="fig" rid="F1">1</xref>). In general, the GB axis is important regulating gastric and intestinal function and energy homeostasis (<xref ref-type="bibr" rid="B11">11</xref>). The tenth cranial nerve or vagus nerve, with its both afferent and efferent fibers (<xref ref-type="bibr" rid="B32">32</xref>), is a link between the gastrointestinal tract and the brain (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). The anterior vagal trunk bifurcates into three limbs: hepatic, anterior or ventral gastric, and celiac branches (<xref ref-type="bibr" rid="B34">34</xref>). In the gastrointestinal tract, at the gastric level, in the lamina propria or mucosa lamina propria, in both external muscularis propria, and in the myenteric plexus are neuronal terminals (<xref ref-type="bibr" rid="B34">34</xref>). In the gastric mucosa, afferent fibers of the vagus nerve are able to identify the presence of ghrelin and leptin (<xref ref-type="bibr" rid="B33">33</xref>). Also, at the level of the small intestine, it has been noted a complex net of vagal afferent fibers (<xref ref-type="bibr" rid="B34">34</xref>), which has similarities to these observed at the gastric level (<xref ref-type="bibr" rid="B34">34</xref>). It has been suggested that afferent fibers of the vagus nerve could identify the presence of luminal contents (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>), being this possible by the presence of mechanosensors (e.g., serosal receptors, mucosal touch receptors, muscular tension receptors) (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Apparently, chemoreceptors of the vagal afferent fibers are reactive to different molecules, such as glucagon-like peptide-1 (GLP-1) (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>), interleukin-1β (IL-1β) (<xref ref-type="bibr" rid="B34">34</xref>), serotonin (5-HT) (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>), somatostatin or growth hormone inhibiting hormone (<xref ref-type="bibr" rid="B34">34</xref>), and cholecystokinin (CCK) (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>), being duodenal vagal afferent fibers reactive to both 5-HT and CCK (<xref ref-type="bibr" rid="B33">33</xref>), and at the level of the ileum, colon, and rectum, afferent fibers of the vagus are reactive to peptide YY and GLP-1 (<xref ref-type="bibr" rid="B33">33</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>The MGB axis, including the hypothalamic–pituitary–adrenal (HPA) axis. The MGB axis is a bidirectional system that links the gastrointestinal tract with the brain. It is a complex system characterized by a neuroendocrine–immune communication. The gut microbiome influences the function of the brain by modulation of both immune and endocrine systems, HPA axis, neurotransmitter pathways, and growth factors. Alterations of this network—that includes numerous molecules and cells—may be the basis of pathological processes.</p>
</caption>
<graphic xlink:href="fpsyt-08-00153-g001"></graphic>
</fig>
<p>The nucleus tractus solitarius (NTS) of the dorsal vagal complex of the brainstem integrates nervous signals from the gastrointestinal tract (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). Also, these vagal and spinal signals are later transmitted to the hypothalamus (<xref ref-type="bibr" rid="B35">35</xref>). Seemingly, the activation of nerve cells from the NTS associated with the afferent vagal system is mainly dependent on <italic>N</italic>-methyl-<sc>d</sc>-aspartate receptors (<xref ref-type="bibr" rid="B35">35</xref>), but this is not clear (<xref ref-type="bibr" rid="B34">34</xref>). Also both the infundibular or arcuate nucleus (ARC)—the third largest hypothalamic aggregation of nerve cells (<xref ref-type="bibr" rid="B36">36</xref>)—and the paraventricular nucleus (PVN) in the hypothalamus receive projections from the NTS (<xref ref-type="bibr" rid="B35">35</xref>). There is evidence that signals from the afferent vagal system are also transmitted to brain regions outside the hypothalamus, such as insula, stria terminalis, and amygdalae (<xref ref-type="bibr" rid="B34">34</xref>).</p>
<p>Since the gut microbiome may influence the central nervous system (CNS) (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B31">31</xref>), it has been proposed to include the microbiome as part of this axis (<xref ref-type="bibr" rid="B10">10</xref>), being known as microbiome–gut–brain (MGB) axis (<xref ref-type="bibr" rid="B10">10</xref>) or microbiota–gut–brain axis (Table <xref ref-type="table" rid="T1">1</xref>) (<xref ref-type="bibr" rid="B16">16</xref>). Gut microbiome is able to mediate host gene expression (<xref ref-type="bibr" rid="B11">11</xref>). This is particularly important if we consider that this could include genes related to CNS function (<xref ref-type="bibr" rid="B11">11</xref>). It has been suggested that gut microbiome influences the CNS by modulation of the hypothalamic–pituitary–adrenal (HPA) axis, immune system, neurotransmitter pathways, and growth factors (Figure <xref ref-type="fig" rid="F1">1</xref>) (<xref ref-type="bibr" rid="B10">10</xref>). A link between disrupted gastrointestinal microbiome and both behavioral and cognitive alterations has been noted (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B37">37</xref>). Also, an adequate performance at the learning and memory level has been related to a functional microbiome (<xref ref-type="bibr" rid="B37">37</xref>). Changes at the level of the HPA axis have been associated with microbiome composition (<xref ref-type="bibr" rid="B16">16</xref>), including both behavioral and cognitive alterations that are apparently linked with molecules, such as norepinephrine (NE), 5-HT, brain-derived neurotrophic factor (BDNF), and dopamine (DA) (<xref ref-type="bibr" rid="B16">16</xref>). Apparently, gut microbiome is able to modulate the function of limbic system (<xref ref-type="bibr" rid="B37">37</xref>), including regions such as amygdala and hypothalamus (<xref ref-type="bibr" rid="B37">37</xref>). Emotional stress appears to impact gut microbiome composition (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Also, the pathophysiology of neuropsychiatric disorders, such as depression (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B37">37</xref>), schizophrenia (<xref ref-type="bibr" rid="B10">10</xref>), anxiety (<xref ref-type="bibr" rid="B37">37</xref>), and autism (<xref ref-type="bibr" rid="B37">37</xref>), appears to involve gut microbiome changes (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B37">37</xref>). Interestingly, behavior appears to play a role to define the characteristics of gastrointestinal microbiome (<xref ref-type="bibr" rid="B37">37</xref>). Individual level of social interaction has been linked directly with microbiome composition (<xref ref-type="bibr" rid="B37">37</xref>), including behavioral characteristics on the list of modulation factors for gut microorganisms (<xref ref-type="bibr" rid="B37">37</xref>). In this bidirectional system, the gastrointestinal microbiota seems to modulate both neuronal function and behavior (<xref ref-type="bibr" rid="B38">38</xref>), including behaviors such as anxiety and appetite behavior (<xref ref-type="bibr" rid="B38">38</xref>). Apparently, these processes involve the interaction of both the MGB and HPA axis (<xref ref-type="bibr" rid="B38">38</xref>). Also, appetite regulation could be modulated—<italic>via</italic> a endocrino-neuronal vagal-hypothalamic communication (<xref ref-type="bibr" rid="B19">19</xref>)—by molecules that are produced by gut microorganisms (<xref ref-type="bibr" rid="B19">19</xref>). It has been noted that brain reactions <italic>via</italic> stress are able to alter gastrointestinal function (<xref ref-type="bibr" rid="B16">16</xref>), including gut microbiome composition changes (<xref ref-type="bibr" rid="B16">16</xref>), and early life disruption of the MGB axis have been associated with later life neuropsychiatric disorders such as depression (<xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>To date, numerous studies using probiotics have attempted to demonstrate MGB axis’ communication (<xref ref-type="bibr" rid="B16">16</xref>). Administration of probiotics has been associated with neurophysiological changes (<xref ref-type="bibr" rid="B16">16</xref>), where it seems to include the participation of different molecules, such as 5-HT, BDNF, DA, NE, and corticotropin releasing factor (<xref ref-type="bibr" rid="B16">16</xref>). Between the different species that are employed as probiotics to improve gastrointestinal equilibrium <italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic> are well-known (<xref ref-type="bibr" rid="B38">38</xref>). Bacterial reconstitution of <italic>B. infantis</italic> has been associated with an improved HPA axis’ response to stress in a neurodevelopmental animal model (<xref ref-type="bibr" rid="B39">39</xref>). Also, probiotic administration of <italic>Lactobacillum rhamnosus</italic>, for a month (<xref ref-type="bibr" rid="B40">40</xref>), is enough to modulate both neuronal gene expression and behavior in animals (<xref ref-type="bibr" rid="B40">40</xref>). In general, this information tries to expose the importance of the MGB axis at the neurobiological level (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>).</p>
</sec>
<sec id="S2-2">
<title>The Microbiome–Gut–Brain Axis and the Immune System</title>
<p>The immune system is an important part of the MGB axis. The immune system, including both adaptive and innate immune systems (<xref ref-type="bibr" rid="B27">27</xref>), mediates the communication between bacteria, gastrointestinal tract, and CNS (<xref ref-type="bibr" rid="B27">27</xref>). Also, a gastrointestinal microbiome is of great significance for an adequate gut immunity (<xref ref-type="bibr" rid="B41">41</xref>). Host’s microbiota is the main source of microorganism antigens for the host (<xref ref-type="bibr" rid="B20">20</xref>). In humans, during development host’s microbiota is an important element modulating the immune system maturation (<xref ref-type="bibr" rid="B20">20</xref>), being host’s intestinal microorganisms involved in the formation of the lymphoid tissue at the gut level (<xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>It is important to remember that the intestine is an anatomical barrier that makes possible the separation between visceral systems and indigenous bacteria (<xref ref-type="bibr" rid="B42">42</xref>). Most of the cells that are part of the intestinal epithelium are columnar epithelial cells (<xref ref-type="bibr" rid="B41">41</xref>). Proteins related to the innate immune system, such as toll-like receptor (TLR) 1–3 (TLR1-TLR3), TLR5, TLR9, and nucleotide oligomerization domain 2—which are part of the pattern recognition receptors (<xref ref-type="bibr" rid="B41">41</xref>)—, and chemotactic factors are expressed by epithelial cells (<xref ref-type="bibr" rid="B41">41</xref>). In the small intestine, T-lymphocytes—which are known as intraepithelial lymphocytes (<xref ref-type="bibr" rid="B41">41</xref>)—are part of the epithelium (<xref ref-type="bibr" rid="B41">41</xref>). Interestingly, gut microorganisms are able to modulate epithelial gene expression <italic>via</italic> molecules related to the immune system such as TLR (<xref ref-type="bibr" rid="B20">20</xref>). Peyer’s patches are well-known lymphoid structures that are part of the small intestine (<xref ref-type="bibr" rid="B41">41</xref>), being important gut-associated immune structures (<xref ref-type="bibr" rid="B41">41</xref>). The mucus produced by goblet cells in the intestine, in both large and small portions (<xref ref-type="bibr" rid="B41">41</xref>), integrates a functional barrier that has an important role as defensive layer against pathogens (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Both the glycoprotein mucin and different polysaccharides are the main components of this mucus (<xref ref-type="bibr" rid="B9">9</xref>), which is degraded principally by gut microbiota (<xref ref-type="bibr" rid="B9">9</xref>). The large intestine is a B-lymphocytes-rich zone (<xref ref-type="bibr" rid="B41">41</xref>). Dysbiosis at the gastrointestinal level has been associated with an elevated activity of molecules associated to the immune system such as cytokines (<xref ref-type="bibr" rid="B42">42</xref>). As consequence of this elevated activity, it has been recognized an intestinal barrier dysfunction (<xref ref-type="bibr" rid="B42">42</xref>), which is accompanied for chronic inflammation (<xref ref-type="bibr" rid="B42">42</xref>). Gut immunoglobulin (Ig) A is an important regulator of microbiome composition (<xref ref-type="bibr" rid="B41">41</xref>). Epithelial cells are provided with antimicrobial molecules that together with IgA improve both transport and anti-bacterial protection at the intestinal level (<xref ref-type="bibr" rid="B43">43</xref>). The intestinal epithelial barrier—which is a barrier against pathological microorganisms (<xref ref-type="bibr" rid="B44">44</xref>)—reduces the risk of intestinal inflammation (<xref ref-type="bibr" rid="B44">44</xref>). Mucosal enteric glial cells (EGCs) are important part of the immune-homeostasis of the gut microenvironment (<xref ref-type="bibr" rid="B44">44</xref>). EGCs are immune cells that are able to present antigens to T-lymphocytes (<xref ref-type="bibr" rid="B44">44</xref>). It is known that these cells are implicated in the production of different factors—such as neurotrophins, glial-derived s-nitrosoglutathione, glial-derived neurotrophic factor, transforming growth factor-β1, and 15-deoxy-Δ<sup>12,14</sup>-prostaglandin J2 (15dPGJ2) (<xref ref-type="bibr" rid="B44">44</xref>)—associated with the homeostasis of the neuroimmune system (<xref ref-type="bibr" rid="B44">44</xref>). Moreover, neurotransmitter signaling alterations of the serotonergic system in both nervous system and gastrointestinal tract have been associated with intestinal inflammatory disorders (<xref ref-type="bibr" rid="B45">45</xref>), suggesting a link trough 5-HT between gut and brain (<xref ref-type="bibr" rid="B45">45</xref>).</p>
<p>Different microorganisms that are part of the gut microbiome have been linked with anti-inflammatory or inflammatory immune reactions (<xref ref-type="bibr" rid="B41">41</xref>). <italic>Bacteroides fragilis</italic> and <italic>Lactobacillus</italic> have been associated with anti-inflammatory responses (<xref ref-type="bibr" rid="B41">41</xref>). Also, protective intestinal inflammation has been linked with gut microorganisms such as segmented filamentous bacteria (<xref ref-type="bibr" rid="B41">41</xref>). A positive inflammatory modulation has been related to bacteria such as <italic>Clostridia</italic> (<xref ref-type="bibr" rid="B41">41</xref>). Apparently, indigenous microbiota has an immunomodulatory potential in gut mucosa (<xref ref-type="bibr" rid="B41">41</xref>), regulating both immune cells and molecules (<xref ref-type="bibr" rid="B41">41</xref>). Interestingly, it has been observed that there is a link between chronic inflammation and gut microbiota (<xref ref-type="bibr" rid="B21">21</xref>), where high level of intestinal oxygen alters normal bacterial composition and induces inflammation (<xref ref-type="bibr" rid="B21">21</xref>). Apparently, high level of gut oxygen drastically damages gut-microbiota equilibrium (<xref ref-type="bibr" rid="B21">21</xref>), reducing anaerobic population and increasing aerobic inhabitants (<xref ref-type="bibr" rid="B21">21</xref>). In general, the MGB axis has a strong link to the immune system.</p>
</sec>
<sec id="S2-3">
<title>The Microbiome–Gut–Brain Axis and Energy Homeostasis</title>
<p>The gastrointestinal tract is an important organ that has different functions, such as nutritional, absorptive, and homeostatic. The small intestine has numerous enzymes that mediate nutritional and digestive processes (<xref ref-type="bibr" rid="B21">21</xref>), being in the intestine the small segment where the most of the absorptive and digestive activities take place (<xref ref-type="bibr" rid="B21">21</xref>). Reabsorption of water, degradation of dietary fiber, and vitamins’ uptake occur mainly in the large intestine (<xref ref-type="bibr" rid="B21">21</xref>). The gastrointestinal tract has its own microbiome. Gut microorganisms are important for both homeostasis and carbohydrate metabolism in human host (<xref ref-type="bibr" rid="B9">9</xref>). Around 10% of host’s caloric intake has a bacterial origin (<xref ref-type="bibr" rid="B20">20</xref>). Gastrointestinal microbiome can be directly influenced by our habitual food (<xref ref-type="bibr" rid="B46">46</xref>), being diet a complex environmental factor that plays an important role shaping gut microbiota (<xref ref-type="bibr" rid="B46">46</xref>). Apparently, host’s feeding behavior rhythms have an impact in the gut bacterial distribution (<xref ref-type="bibr" rid="B19">19</xref>), being host’s circadian rhythm alterations able to trigger a change in the quantity of intestinal microorganism that normally predominates during the diurnal period (<xref ref-type="bibr" rid="B19">19</xref>). Complex molecules such as polysaccharides are metabolized for bacteria that inhabit the gastrointestinal tract (<xref ref-type="bibr" rid="B9">9</xref>), working altogether as a metabolic organ in the human body (<xref ref-type="bibr" rid="B9">9</xref>). Moreover, gut microbiota makes these polymeric carbohydrate molecules an energy source for the host (<xref ref-type="bibr" rid="B9">9</xref>). Intestinal bacteria are involved in the metabolism of macronutrients and the metabolites produced for these microorganisms are able to modulate epigenetic changes in the host (<xref ref-type="bibr" rid="B46">46</xref>). A diet, including a high amount of fiber, polyphenols (Table <xref ref-type="table" rid="T1">1</xref>)—present in green tea, nuts, and fruits (<xref ref-type="bibr" rid="B46">46</xref>)—and omega-3 fatty acids—available in fish oil (<xref ref-type="bibr" rid="B46">46</xref>)—has been linked with bacterial changes—e.g., a rise in the number of both <italic>Lactobacillus</italic> and <italic>Bifidobacteria</italic> (<xref ref-type="bibr" rid="B46">46</xref>)—at the gastrointestinal level (<xref ref-type="bibr" rid="B46">46</xref>). Gut microbiota—including microorganism, such as <italic>Clostridium coccoides</italic>, Actinobacteria, <italic>Roseburia, Bifidobacteria, Lactobacillus, Escherichia coli, Peptostreptococcus, B. thetaiotaomicron</italic>, and <italic>Enterococcus faecalis</italic> (<xref ref-type="bibr" rid="B46">46</xref>)—is associated with the metabolism of these dietary components (<xref ref-type="bibr" rid="B46">46</xref>). Interestingly, alterations at the level of the gut bacterial population’s growth have been linked with the presence of a disrupted metabolic control (<xref ref-type="bibr" rid="B19">19</xref>). It has been suggested that the intestinal microorganisms could regulate their own homeostatic control of energy balance by using their host’s energy homeostasis mechanisms (<xref ref-type="bibr" rid="B19">19</xref>). An increment or reduction in the number of gut bacteria could induce a feeling of lack of food or satiety in the host (<xref ref-type="bibr" rid="B19">19</xref>).</p>
<p>The CNS has a pivotal role in the homeostatic regulation of energy balance (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B47">47</xref>). Different chemical and neuronal signals from peripheral organs are involved in the energy homeostasis process (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B47">47</xref>). In the brain, the hypothalamus plays an important role regulating body metabolism (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B47">47</xref>). This brain region is involved in the control of body weight, food intake, and thermoregulation (<xref ref-type="bibr" rid="B47">47</xref>). Both peripheral hormones, such as insulin and leptin, and numerous nutrients modulate—<italic>via</italic> hypothalamus—the control of energy homeostasis (<xref ref-type="bibr" rid="B48">48</xref>). Leptin and insulin are implicated in the CNS in the food reward system (<xref ref-type="bibr" rid="B48">48</xref>). Also, there are pieces of evidence about the expression of receptors for leptin and insulin in diverse brain areas (<xref ref-type="bibr" rid="B48">48</xref>), including a complex system in the CNS for energy regulation (<xref ref-type="bibr" rid="B48">48</xref>). The initial contact with consumed food takes place in the gastrointestinal tract (<xref ref-type="bibr" rid="B35">35</xref>), being the GB axis fundamental to preserve—as product of neuroendocrine communication (<xref ref-type="bibr" rid="B35">35</xref>)—the balance between energy intake and energy expenditure in the body (<xref ref-type="bibr" rid="B35">35</xref>). Apparently, the homeostasis of gut microorganisms plays an important role in the energy homeostasis of the host (<xref ref-type="bibr" rid="B19">19</xref>), being appetite control a fundamental mechanism for host–bacteria homeostasis (<xref ref-type="bibr" rid="B19">19</xref>). The integration of this microbiota–host communications appears to be <italic>via</italic> gastrointestinal tract-hypothalamus (<xref ref-type="bibr" rid="B19">19</xref>).</p>
<p>In general, neuronal population from the ARC and the PVN is important regulating energy homeostasis (<xref ref-type="bibr" rid="B47">47</xref>). Both orexigenic and anorexigenic cells (Table <xref ref-type="table" rid="T1">1</xref>) are present in the ARC (<xref ref-type="bibr" rid="B47">47</xref>). Agouti-related protein (AgRP) and neuropeptide Y (NPY) are expressed for the first kind of neurons (<xref ref-type="bibr" rid="B47">47</xref>), while anorexigenic nerve cells express proopiomelanocortin (POMC) (<xref ref-type="bibr" rid="B47">47</xref>). In the brain, orexigenic and anorexigenic neurons have projections to both hypothalamic—lateral hypothalamus, PVN, ventromedial nucleus, and dorsomedial hypothalamic nucleus—and extra-hypothalamic areas (<xref ref-type="bibr" rid="B32">32</xref>). An increased need for food has been associated with AgRP—by melanocortin 4 receptor (MC4R) related action—and NPY—by NPY receptor linked activity—(<xref ref-type="bibr" rid="B32">32</xref>). Both POMC and NPY neurons are known as main sites of expression of leptin receptors (<xref ref-type="bibr" rid="B49">49</xref>). Leptin, which body concentration is depended of adipose tissue grade (<xref ref-type="bibr" rid="B50">50</xref>), is a hormone with implications in both body weight and metabolism (<xref ref-type="bibr" rid="B50">50</xref>). Leptin has a satiety factor function through inhibition of both AgRP and NPY cells and activation of POMC neurons (<xref ref-type="bibr" rid="B32">32</xref>). In the case of POMC cells, it has been proposed that the effect of leptin on this kind of neurons occurs in the ARC (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>), where the frequency of action potentials is increased by leptin (<xref ref-type="bibr" rid="B49">49</xref>). As mechanism for this action, it has been proposed that leptin induces both depolarization of POMC nerve cells and decrement of gamma-aminobutyric acid release onto POMC cells (<xref ref-type="bibr" rid="B49">49</xref>). Also, the peptide hormone known as α-melanocyte stimulating hormone (α-MSH), an agonist of the MC4R (<xref ref-type="bibr" rid="B32">32</xref>), is produced by POMC neurons from the ARC (<xref ref-type="bibr" rid="B47">47</xref>). The NTS and the vagal system are involved increasing appetite by ghrelin action (<xref ref-type="bibr" rid="B32">32</xref>). Ghrelin activates orexigenic neurons and suppresses anorexigenic cells (<xref ref-type="bibr" rid="B32">32</xref>). In general, gut microbiota play an important role in human energy homeostasis.</p>
</sec>
</sec>
<sec id="S3">
<title>The Gut Microbiome and Neurodevelopment</title>
<p>Our bacterial composition, this one that we have during our adult life, starts to be acquired during our early life (<xref ref-type="bibr" rid="B42">42</xref>), being the mother the main element defining the characteristics of the infant’s microbiome (<xref ref-type="bibr" rid="B30">30</xref>). Normally, the gut is firstly exposed to microbes at birth (<xref ref-type="bibr" rid="B7">7</xref>). Apparently, human’s first bacteria come from mother’s vagina and excrement (<xref ref-type="bibr" rid="B4">4</xref>). There is some evidence to suggest that the placenta has a microbiome (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). Data from metagenomic information indicate the presence of an indigenous microbiota in human placenta (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). Since bacteria—such as <italic>E. coli, Staphylococcus epidermidis</italic> and <italic>E. faecalis</italic> (<xref ref-type="bibr" rid="B53">53</xref>)—have been isolated from meconium (Table <xref ref-type="table" rid="T1">1</xref>) from healthy newborns (<xref ref-type="bibr" rid="B53">53</xref>), it is believed that there is an intrauterine contact between healthy fetus and microorganisms (<xref ref-type="bibr" rid="B53">53</xref>). Also, it is believed that there is a fetus–maternal–bacteria interaction (<xref ref-type="bibr" rid="B52">52</xref>), since it has been noted a bacterial presence in the amniotic fluid, from mothers, and meconium, from neonates, both without antibiotic contact (<xref ref-type="bibr" rid="B52">52</xref>). However, with little scientific experiences, very few data available and discussible methodologies, caution must be applied, and the question about a possible prenatal human microbiome is still open. In general, the physiological gut composition is not clear (<xref ref-type="bibr" rid="B30">30</xref>), but it is known that the gastrointestinal bacterial composition is different during childhood and adulthood (<xref ref-type="bibr" rid="B30">30</xref>). It is important to note that <italic>E. coli</italic> is one of the first microorganisms that inhabit the infant gut (<xref ref-type="bibr" rid="B30">30</xref>).</p>
<p>A link between microbiome composition and neurodevelopment has been proposed (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B38">38</xref>), where functional changes in different brain regions (e.g., hypothalamus, amygdala, hippocampus, and striatum) are present (<xref ref-type="bibr" rid="B16">16</xref>). Microorganisms could influence neurodevelopment (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Development of the enteric nervous system (ENS)—which have EGCs as main component (<xref ref-type="bibr" rid="B44">44</xref>)—is regulated by gastrointestinal microorganisms (<xref ref-type="bibr" rid="B38">38</xref>). EGCs are important transmitting signals related to the ENS (<xref ref-type="bibr" rid="B44">44</xref>). Gut microbiome composition has been associated with neuronal connectivity development (<xref ref-type="bibr" rid="B16">16</xref>). Also, bacteria seem to be associated with the quality of neuronal circuitries during the postnatal life (<xref ref-type="bibr" rid="B28">28</xref>). It has been discussed that alterations of the gut microbiome, during the prenatal and the postnatal period (<xref ref-type="bibr" rid="B10">10</xref>), may affect the normal neurodevelopment (<xref ref-type="bibr" rid="B10">10</xref>). It has been hypothesized that neurodevelopment could be mediated by host–microorganisms <italic>via</italic> MGB axis (<xref ref-type="bibr" rid="B42">42</xref>). Since molecules involved in the neural development such as neurotrophic factors, including BDNF (<xref ref-type="bibr" rid="B54">54</xref>), have been related with the MGB and HPA axis (<xref ref-type="bibr" rid="B16">16</xref>), and they are susceptible of modulation <italic>via</italic> epigenetic regulation (<xref ref-type="bibr" rid="B54">54</xref>), microbiome alterations could influence strongly on the neurodevelopment. This epigenetic regulation may be result of gut microbiota-host chemical communication (<xref ref-type="bibr" rid="B55">55</xref>), where bacterial bioactive metabolites—e.g., butyrate (<xref ref-type="bibr" rid="B55">55</xref>)— and signaling molecules—e.g., peptides and endotoxins (<xref ref-type="bibr" rid="B55">55</xref>)—make possible this communication (<xref ref-type="bibr" rid="B55">55</xref>). Moreover, brain development may be modulated by the MGB axis involving the participation of the neuro-endocrino-immunological system (<xref ref-type="bibr" rid="B43">43</xref>).</p>
<p>Recently, an association between a disrupted microbiome and abnormal neurodevelopment has been noted (<xref ref-type="bibr" rid="B56">56</xref>). Germ-free (GF) mice (Table <xref ref-type="table" rid="T1">1</xref>)—which are animals with a microbiota deficit from birth (<xref ref-type="bibr" rid="B56">56</xref>), being a helpful tool to study microbiome–brain interactions (<xref ref-type="bibr" rid="B56">56</xref>)—have showed neuroanatomical changes in brain areas, such as amygdala and hippocampus, during the late adolescent/early adulthood period (<xref ref-type="bibr" rid="B56">56</xref>). These changes included neuronal morphological aberrations, such as basilar dendrites with thin spines (<xref ref-type="bibr" rid="B56">56</xref>), hypertrophy of aspiny interneurons from the basolateral complex (BLA) (<xref ref-type="bibr" rid="B56">56</xref>), pyramidal neurons with long dendrites (<xref ref-type="bibr" rid="B56">56</xref>), short pyramidal neurons in the ventral hippocampus (<xref ref-type="bibr" rid="B56">56</xref>), and reduction of stubby spines of the hippocampal pyramidal neurons (<xref ref-type="bibr" rid="B56">56</xref>). Also, it has been proposed that gut bacteria have an important impact in early neurodevelopment (<xref ref-type="bibr" rid="B42">42</xref>), with the participation of both microglia and endocrine molecules as modulator factor (<xref ref-type="bibr" rid="B42">42</xref>) and emotional stress and/or antibiotics—for example—as risk factors (<xref ref-type="bibr" rid="B42">42</xref>). Published in 2004, results from experiments from a developmental model using GF mice have reported that alterations at the level of early postnatal microbiota affect both the HPA axis and the limbic system (<xref ref-type="bibr" rid="B39">39</xref>), including both elevated level of plasma adrenocorticotropic hormone and corticosterone after stress exposition and reduced level of BDNF in brain regions, such as hippocampus and cortex (<xref ref-type="bibr" rid="B39">39</xref>). All these data where observed when GF mice were compared with mice having a specific microbiota (<xref ref-type="bibr" rid="B39">39</xref>), suggesting an important neurodevelopmental role for indigenous microbiota regulating HPA axis (<xref ref-type="bibr" rid="B39">39</xref>). In general, in the human life cycle, there are prenatal and postnatal environmental factors that play an important role defining the characteristics of each microbiome (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B31">31</xref>), and during the different host life cycles have been observed microbiota age-related changes that could be determined by microbiota’s genes (<xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>Evidence suggests that there is an important role played by gut microbiome in human brain development. However, the whole association between the MGB and human neurodevelopment is still unknown.</p>
</sec>
<sec id="S4">
<title>The Gut Microbiome and the Depressive Syndrome, from a Neurodevelopmental Perspective</title>
<p>Human intestine formation is concluded around the 12th week of intrauterine life (<xref ref-type="bibr" rid="B57">57</xref>). Early during the prenatal period begins the formation of the MGB axis (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). Main cells of the ENS are product of the migration of neural crest cells (<xref ref-type="bibr" rid="B57">57</xref>). Neural crest cells can be observed in the early gastrointestinal organ around 7–12 weeks of gestation (<xref ref-type="bibr" rid="B57">57</xref>). It is important to note that the interstitial cells of Cajal have a different origin (<xref ref-type="bibr" rid="B57">57</xref>), being of mesenchymal basis (<xref ref-type="bibr" rid="B57">57</xref>). It has been reported that neurons such as 5-HT enteric cells are born early during the intrauterine life (<xref ref-type="bibr" rid="B58">58</xref>). In general, 5-HT is an important neurotransmitter in the MGB axis (<xref ref-type="bibr" rid="B45">45</xref>). This molecule is susceptible of modulation <italic>via</italic> gut bacteria (<xref ref-type="bibr" rid="B45">45</xref>). Together with 5-HT, molecules such as TLRs and short chain fatty acids have been proposed as participants in the GB axis’ function that show a strong link to gut microbiota composition (<xref ref-type="bibr" rid="B43">43</xref>). In the newborn, during the first weeks of extrauterine life (<xref ref-type="bibr" rid="B58">58</xref>), there is a strong functional connection between both enteric neuronal cells and glial cells (<xref ref-type="bibr" rid="B58">58</xref>), being a critical period for alterations induced by environmental factors (<xref ref-type="bibr" rid="B58">58</xref>). Expression and activation of the receptor tyrosine kinase RET seem fundamental for ENS development (<xref ref-type="bibr" rid="B58">58</xref>). During the early development the immune system and its molecules—e.g., cytokines (<xref ref-type="bibr" rid="B58">58</xref>)—and cells—e.g., macrophages (<xref ref-type="bibr" rid="B58">58</xref>)—play an important role modulating the formation of neuronal circuits at the gastrointestinal level (<xref ref-type="bibr" rid="B58">58</xref>). During the neonatal period, a positive modulation of the immune system has been associated with breastfeeding (<xref ref-type="bibr" rid="B59">59</xref>). It seems that the basis of the MGB axis and its link with the neurodevelopment is by modulation of cells and molecules that integrate the neuroendocrine-immunological system (<xref ref-type="bibr" rid="B43">43</xref>).</p>
<p>It has been suggested that the presence of a neuropsychiatric disorder is frequently associated with the existence of a gastrointestinal illness (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Also, gastrointestinal diseases have been linked with gut microbiome dysbiosis (<xref ref-type="bibr" rid="B60">60</xref>). Early life stress such as neonatal maternal separation has been connected with intestinal dysfunction (<xref ref-type="bibr" rid="B61">61</xref>). A characteristic gut microbiota in depression has been reported in humans (<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>), including both high level of Bacteroidales and low Lachnospiraceae composition in a first study (<xref ref-type="bibr" rid="B62">62</xref>), and both an increased <italic>Alistipes</italic> population and Enterobacteriaceae level and low grade of <italic>Faecalibacterium</italic> in a second one (<xref ref-type="bibr" rid="B63">63</xref>) in depression (<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>). Interestingly, it has been noted that <italic>Faecalibacterium</italic> has a protective effect for neuropsychiatric disorders such as depression (<xref ref-type="bibr" rid="B63">63</xref>). In general, this information suggests a relation between the gastrointestinal system and the nervous system, with a strong communication at the level of the MGB axis.</p>
<p>The development of our MGB axis begins early in life, including a complex neuroendocrine-immunological modulation. It seems that stress factors, such as emotional stress and gut microbiota alterations, play an important role modulating the risk for diseases such as depression.</p>
<sec id="S4-1">
<title>The Neurodevelopmental Theory of Depression: An Overview</title>
<p>Neurodevelopment is an important process to understand the depressive syndrome. It is a dynamic process with a long trajectory (<xref ref-type="bibr" rid="B64">64</xref>), from gestation to adulthood (<xref ref-type="bibr" rid="B64">64</xref>). The neurodevelopmental theory of the depressive syndrome has been reviewed recently elsewhere (<xref ref-type="bibr" rid="B65">65</xref>). Each human brain region has its maturation time period (<xref ref-type="bibr" rid="B65">65</xref>), being the most relevant morphological modifications during the prenatal period, childhood, and early adolescence (<xref ref-type="bibr" rid="B65">65</xref>). The beginning of the human neurodevelopment is around the third and fourth week of intrauterine life (<xref ref-type="bibr" rid="B66">66</xref>, <xref ref-type="bibr" rid="B67">67</xref>) with the neurulation as first event (<xref ref-type="bibr" rid="B66">66</xref>–<xref ref-type="bibr" rid="B68">68</xref>). It has been reported that the dorsolateral prefrontal cortex is one of the final brain regions to mature (<xref ref-type="bibr" rid="B69">69</xref>).</p>
<p>It has been noted that the depressive syndrome and both structural and functional abnormalities at the level of the limbic system, which are associated with the disease, are product of early neurodevelopmental alterations (<xref ref-type="bibr" rid="B65">65</xref>). Risk factors, such as altered fetal period (<xref ref-type="bibr" rid="B70">70</xref>), maternal malnutrition (<xref ref-type="bibr" rid="B71">71</xref>), maternal stress (<xref ref-type="bibr" rid="B71">71</xref>), child abuse (<xref ref-type="bibr" rid="B72">72</xref>), and malnutrition (<xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>), are able to trigger these early neurodevelopment disruptions (<xref ref-type="bibr" rid="B65">65</xref>). A multi-genetic susceptibility for depression (<xref ref-type="bibr" rid="B75">75</xref>) can be modulated by one or more of these risk factors (<xref ref-type="bibr" rid="B76">76</xref>). Also, gene expression is susceptible of alterations by epigenetic mechanisms (<xref ref-type="bibr" rid="B77">77</xref>) such as DNA methylation (<xref ref-type="bibr" rid="B78">78</xref>–<xref ref-type="bibr" rid="B80">80</xref>). As consequence of these genetic dysfunctions both endocrinological alterations—e.g., HPA axis changes (<xref ref-type="bibr" rid="B81">81</xref>) and leptin alterations (<xref ref-type="bibr" rid="B65">65</xref>)—and immunological aberrations—e.g., elevated immune activity (<xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B83">83</xref>)—are responsible for the disorder observed at the level of monoamines in depression—e.g., noradrenergic and serotonergic neurotransmission alterations (<xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B84">84</xref>), being a BDNF modulation suggested as link between the endocrino-immunological alterations and the depressive phenotype (<xref ref-type="bibr" rid="B65">65</xref>).</p>
<p>In general, the neurodevelopmental theory of depression points out that very early and early stress factors in life are able to trigger the depressive phenotype later in life (<xref ref-type="bibr" rid="B65">65</xref>), which is accompanied by signs and symptoms, such as hippocampal (<xref ref-type="bibr" rid="B85">85</xref>) and amygdala atrophy (<xref ref-type="bibr" rid="B86">86</xref>), emotional and behavioral changes (<xref ref-type="bibr" rid="B87">87</xref>–<xref ref-type="bibr" rid="B90">90</xref>), and minor physical anomalies (Table <xref ref-type="table" rid="T1">1</xref>) (<xref ref-type="bibr" rid="B91">91</xref>). Since microbiota has the potential to influence the brain during the development (<xref ref-type="bibr" rid="B92">92</xref>) and changes at the level of indigenous gut bacteria could be produced by stress (<xref ref-type="bibr" rid="B92">92</xref>), it has been noted that the MGB axis could be linked to the pathophysiology of depression.</p>
</sec>
<sec id="S4-2">
<title>The Microbiome–Gut–Brain Axis and the Etiology of the Depressive Syndrome</title>
<p>The evidence presented above suggests that both the communication of the MGB axis and the bacterial modulation of the neurodevelopment involve three different systems that at the same time are strongly linked: the neurological system, the endocrine system, and the immune system. But, where could be the association between the MGB axis and the etiology of the depressive syndrome? There is, in the neurodevelopment! For example, very early exposition to valproic acid during the intrauterine life has been linked to both indigenous microbial alterations and behavioral changes later in life (<xref ref-type="bibr" rid="B93">93</xref>). Also, it has been demonstrated that early bacterial composition modulates neurodevelopment (<xref ref-type="bibr" rid="B94">94</xref>), including changes at the level of genetic expression of genes associated with brain function (<xref ref-type="bibr" rid="B94">94</xref>). This early neurodevelopmental modulation has the effect to influence adult behavior later in life (<xref ref-type="bibr" rid="B94">94</xref>). Moreover, it has been proposed, after hippocampal experimental results (<xref ref-type="bibr" rid="B95">95</xref>), that limbic system’s neurogenesis can be modulated by indigenous microbiota (<xref ref-type="bibr" rid="B95">95</xref>).</p>
<p>In the bidirectionality of the MGB axis, both gastrointestinal and neuropsychiatric pathological entities could be both origin and consequence of stress modulation (<xref ref-type="bibr" rid="B96">96</xref>). Stress factors during critical periods in the neurodevelopment—such as prenatal, postnatal/early childhood, and adolescence (<xref ref-type="bibr" rid="B65">65</xref>)—seem to be enough to develop the depressive phenotype (<xref ref-type="bibr" rid="B65">65</xref>). Since gastrointestinal bacteria have a strong communication with the brain <italic>via</italic> the MGB axis (<xref ref-type="bibr" rid="B96">96</xref>), gut microbiome alterations can be ideal etiological factors related to depression. As it is exposed above, it is not clear if there is a host–bacterial communication in the intrauterine life. If we consider the results published from a Spanish research group that suggest that the meconium from healthy neonates is not a sterile stool (<xref ref-type="bibr" rid="B53">53</xref>), being inhabit for bacteria such as <italic>Enterococcus</italic> and <italic>Staphylococcus</italic> (<xref ref-type="bibr" rid="B53">53</xref>), the GB communication could include the direct participation of bacteria, integrating a very early MGB axis in humans. Microglia are present early in the development (<xref ref-type="bibr" rid="B97">97</xref>). Microglia together with cytokines have a neuro-immune function in the early development (<xref ref-type="bibr" rid="B97">97</xref>, <xref ref-type="bibr" rid="B98">98</xref>), being involved in the process of neuronal cytoarchitectural configuration (<xref ref-type="bibr" rid="B97">97</xref>, <xref ref-type="bibr" rid="B98">98</xref>). If scientific results from studies <italic>in vivo</italic> suggest that very early immune activation has been linked with depressive symptoms later in life (<xref ref-type="bibr" rid="B99">99</xref>) and that gut bacteria can have an influence in early neurodevelopment <italic>via</italic> immune–endocrine communication (<xref ref-type="bibr" rid="B42">42</xref>), it could be possible to think that very early environmental stress factors associated with the etiology of depression modulate the risk to develop depression later in life <italic>via</italic> GB axis. Both microbiome alterations and MGB axis dysfunction have been linked to changes at the level of the HPA axis (<xref ref-type="bibr" rid="B100">100</xref>). Also, a normal HPA axis development requires an adequate gut indigenous bacteria composition early in life (<xref ref-type="bibr" rid="B43">43</xref>). The human development, including the neurodevelopment, is joined by systemic inflammation or inflamm-aging (Table <xref ref-type="table" rid="T1">1</xref>) (<xref ref-type="bibr" rid="B101">101</xref>), which is part of a dysfunction of the immune system or immunosenescence (Table <xref ref-type="table" rid="T1">1</xref>) (<xref ref-type="bibr" rid="B101">101</xref>). Apparently, there is an association between this systemic inflammation and the MGB axis (<xref ref-type="bibr" rid="B101">101</xref>), where stress is a risk factor for molecular, cellular, and behavioral alterations (<xref ref-type="bibr" rid="B101">101</xref>), including HPA axis dysfunction (<xref ref-type="bibr" rid="B101">101</xref>). Data from clinical reports suggest an association between the MGB axis and depression (<xref ref-type="bibr" rid="B102">102</xref>, <xref ref-type="bibr" rid="B103">103</xref>), it has been reported that subjects with depression have elevated levels of IgA and IgM and the presence of gastrointestinal symptoms (<xref ref-type="bibr" rid="B102">102</xref>, <xref ref-type="bibr" rid="B103">103</xref>). Animal studies have found that chronic gastrointestinal inflammation is linked to altered hippocampal neurogenesis (<xref ref-type="bibr" rid="B104">104</xref>). Also, a chronic elevated level of Il-6 was reported (<xref ref-type="bibr" rid="B104">104</xref>).</p>
<p>It has been established that a diet rich in fast-food, such as pizza, hamburgers, and donuts, has been connected to depression (<xref ref-type="bibr" rid="B105">105</xref>), increasing the risk for this syndrome (<xref ref-type="bibr" rid="B105">105</xref>). A diet, including fish and enough vegetables and fruits, can be a protective factor for depression (<xref ref-type="bibr" rid="B106">106</xref>), maybe because this kind of diet has an anti-oxidative and anti-inflammatory impact (<xref ref-type="bibr" rid="B106">106</xref>). Also, the inclusion of probiotics could have a positive effect for depressive patients (<xref ref-type="bibr" rid="B107">107</xref>), being suggested an anti-inflammatory and anti-oxidative effect induced by probiotics (<xref ref-type="bibr" rid="B107">107</xref>). Moreover, probiotics could have the potential to modulate growth factors (<xref ref-type="bibr" rid="B107">107</xref>), including the increment of BDNF levels (<xref ref-type="bibr" rid="B107">107</xref>).</p>
</sec>
</sec>
<sec id="S5">
<title>Conclusion</title>
<p>The evidence presented above suggests that the link between the MGB axis, the neuroendocrine–immune system—including energy homeostasis mechanisms—and the neurodevelopment is strong. Human neurodevelopment is a dynamic and long process that begins very early, during the intrauterine life, and continues during years, into the adulthood. These characteristics of the nervous system’s development—both its chronicity and dynamisms—make this process susceptible for alterations. Moreover, the origin of the GB axis takes place early during the prenatal period, directly after the beginning of the neurodevelopment. The GB bidirectional connection is present early in development, playing this network a key role modulating the formation of the brain. Numerous peripheral neurochemical signals together with intestinal microorganisms—which are host’s energy homeostasis elements—and a vagal communication are active regulator of both metabolism and immunity, mainly <italic>via</italic> the limbic system. Since the gastrointestinal tract has the first contact with diet elements—including the very early consumption of elements from mother’s vagina and excrement at birth—and diet is an important element defining human’s bacterial composition, then the interaction of host–bacteria <italic>via</italic> MGB axis is important regulating the neurodevelopment. The immune system regulates gastrointestinal bacterial composition. Very early nervous formation in the gastrointestinal tract is modulated for both immune cells and molecules. The origin of a depressive syndrome could be possible only in a disrupted brain. Apparently, the MGB axis plays an important role in the pathophysiology of depression. Gut microbiome modulation by environmental stress factors seems to contribute, together with genetic risk factors, to the development of this illness. Probably, these risk factors, which are potentialized by the combination of one or more other risk factors, induce a neuroendocrine–immune dysfunction that is the basis of the alterations observed in depressed subjects. The strong communication between the gastrointestinal system and the brain <italic>via</italic> the GB axis is present very early in the human development. This axis has a characteristic bidirectionality that seems to be attractive as antidepressant therapeutic target, being drugs that are able to induce changes at the inflammatory cascade proposed as antidepressants. Also, it has been recognized that gut microbiota play an important role in inflammation. Since gut bacteria have an important effect at the level of the GB axis and they are involved in both inflammatory and anti-inflammatory human functions, microbiota modulation by diet, probiotics, and drugs has been proposed recently as treatment strategy to improve the symptoms associated with the depressive syndrome. Antibiotics are environmental factors in the industrialized countries that induce important microbiota changes (<xref ref-type="bibr" rid="B108">108</xref>). However, interesting data have suggested that antibiotics such as minocycline have psycho-modulator effects (<xref ref-type="bibr" rid="B109">109</xref>), including antipsychotic and antidepressant functions (<xref ref-type="bibr" rid="B109">109</xref>). Apparently, these effects are associated with the anti-inflammatory, anti-oxidative, neuromodulator, and neuroprotective actions induced by minocycline (<xref ref-type="bibr" rid="B109">109</xref>). By an international systematic review and meta-analysis, it has been reported that anti-inflammatory drugs improve depressive symptoms (<xref ref-type="bibr" rid="B110">110</xref>). Interestingly, it has been reported that drugs, such as mood stabilizers, antipsychotics, and antidepressants, have anti-inflammatory effects (<xref ref-type="bibr" rid="B109">109</xref>). Moreover, an improvement of the pathways associated with the inflammatory cascades has been proposed as drug target in the treatment of depressed patients (<xref ref-type="bibr" rid="B111">111</xref>). Also, as results from different host–microbiota studies both innovative drug targets and new therapeutic strategies have been proposed with the objective of manipulate the human microbiome. These include: intestinal oxygen as therapeutic target (<xref ref-type="bibr" rid="B21">21</xref>), direct manipulation of human microbiota by fecal microbiota transplantation (<xref ref-type="bibr" rid="B21">21</xref>), alteration of microbiota products by diet (<xref ref-type="bibr" rid="B21">21</xref>), and improvement of drugs’ metabolism by microbiota’s modification (<xref ref-type="bibr" rid="B21">21</xref>).</p>
<p>Hippocrates of Kos, who lived around the fourth century BC (<xref ref-type="bibr" rid="B112">112</xref>), pointed out that diet plays an important role in the mental health (<xref ref-type="bibr" rid="B112">112</xref>). Hippocrates expressed this idea by his maxim: “Let food be thy medicine, and medicine be thy food” (<xref ref-type="bibr" rid="B112">112</xref>). Interestingly, this maxim is still being in our time of actuality. Individual lifestyles influence gut microbiota (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B113">113</xref>), being our personal diet—e.g., a diet including food of plant and/or animal origin (<xref ref-type="bibr" rid="B113">113</xref>)—an important element to shape our own microbiome (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B113">113</xref>). It has been noted that, during the extrauterine life, there are numerous transformations at the level of the gastrointestinal bacterial composition (<xref ref-type="bibr" rid="B96">96</xref>). Apparently, our diet has influenced the genome and the microbiome (<xref ref-type="bibr" rid="B5">5</xref>). Moreover, a better knowledge of our microbiome and how to modulate it could be helpful to improve existing medical strategies (<xref ref-type="bibr" rid="B9">9</xref>). Since the above evidence suggests that our early diet has a strong influence in our gut microbiome composition and in the susceptibility to develop different disorders, dietary practices such as breastfeeding during the first months of life, which improve our indigenous gastrointestinal bacteria and reduce the risk to develop future illness (<xref ref-type="bibr" rid="B114">114</xref>), should be intensely promoted. During the development, delivery mode plays an important role defining the characteristics of human microbiota (<xref ref-type="bibr" rid="B115">115</xref>, <xref ref-type="bibr" rid="B116">116</xref>), being important differences in the acquired microbiota from vaginal delivered neonates compared to C-section delivered newborns (<xref ref-type="bibr" rid="B115">115</xref>, <xref ref-type="bibr" rid="B116">116</xref>). Since early microbiota changes have been associated with the development of neurological alterations later in life, it could be possible that, in case of an elective delivery mode, a vaginal delivery should be strongly suggested to our patients, with the objective to reduce—since a neurobiological perspective—the risk for depression in the newborn. This is especially important if we consider that the delivery mode modulates gut microbiota composition particularly during the first 3 days of extrauterine life (<xref ref-type="bibr" rid="B116">116</xref>), an important period in human neurodevelopment.</p>
<p>A better perception of the significance of the MGB axis in the etiology of depression will help us to obtain a better understanding about the pathophysiology of this syndrome. Also, it opens the possibility to offer better treatment strategies to our patients. This will be possible only if we accomplish to decipher the genetic, anatomical, functional, and behavioral characteristics of the human microbiota. The most important limitation in the area of the MGB axis’ research lies in the fact that there is very little knowledge about the gut microbiome. There is necessary more scientific research that helps us to understand the relationship between the different microorganisms that inhabit the gastrointestinal tract. With the objective to understand the role played by microbiome in both human health and human disease, there are born different research consortiums around the world such as the “International Human Microbiome Consortium”<xref ref-type="fn" rid="fn1"><sup>1</sup></xref> (<xref ref-type="bibr" rid="B117">117</xref>), the Irish “Eldermet Project”<xref ref-type="fn" rid="fn2"><sup>2</sup></xref> (<xref ref-type="bibr" rid="B118">118</xref>), the German <italic>Verbund OptiMD im Forschungsnetz für psychische Erkrankungen</italic> or “OptiMD Consortium”<xref ref-type="fn" rid="fn3"><sup>3</sup></xref> (<xref ref-type="bibr" rid="B119">119</xref>), the international project “Metagenomics of the Human Intestinal Tract” or “MetaHIT Project”<xref ref-type="fn" rid="fn4"><sup>4</sup></xref> (<xref ref-type="bibr" rid="B120">120</xref>), and the American “NIH Human Microbiome Project”<xref ref-type="fn" rid="fn5"><sup>5</sup></xref> (<xref ref-type="bibr" rid="B121">121</xref>). In general, current scientific information is not able to explain the entire physiology of the MGB axis (<xref ref-type="bibr" rid="B122">122</xref>). Recently, it has increased the scientific research trying to elucidate the effects of gut microorganism in human behavior (<xref ref-type="bibr" rid="B122">122</xref>), including the link between both the vagal system and the neuroendocrine–immune system in brain function (<xref ref-type="bibr" rid="B122">122</xref>). There is still a wide scientific gap about the role played for the MGB axis in the etiology of different disorders, including neuropsychiatric illness. It is important to mention that the most of the scientific information about the MGB axis are product of animal research, being necessary the development of more human research to understand the host–microbiome interaction. However, it is evident that there is a strong host–microbiome connection, where environmental factors are important modulators of host’s gut microbiota. Apparently, our habits are able to modulate the MGB axis. Thus, an appropriate diet is of central importance for both a suitable neurodevelopment and an adequate mental health.</p>
</sec>
<sec id="S6">
<title>Author Contributions</title>
<p>JL-O, RR, and TB contributed equally to this work.</p>
</sec>
<sec id="S7">
<title>Conflict of Interest Statement</title>
<p>The authors report no biomedical financial interests or potential conflicts of interest. The reviewer, SB, and handling editor declared their shared affiliation and the handling editor states that the process nevertheless met the standards of a fair and objective review.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by the German Federal Ministry of Education and Research (<italic>Bundesministerium für Bildung und Forschung, BMBF</italic>), Research Grant No. 01EE1401B to RR and TB.</p>
</fn>
</fn-group>
<fn-group>
<fn id="fn1">
<p><sup>1</sup><uri xlink:href="http://www.human-microbiome.org/" xlink:type="simple">http://www.human-microbiome.org/</uri>.</p>
</fn>
<fn id="fn2">
<p><sup>2</sup><uri xlink:href="http://eldermet.ucc.ie/" xlink:type="simple">http://eldermet.ucc.ie/</uri>.</p>
</fn>
<fn id="fn3">
<p><sup>3</sup><uri xlink:href="http://www.optimd.de/" xlink:type="simple">http://www.optimd.de/</uri>.</p>
</fn>
<fn id="fn4">
<p><sup>4</sup><uri xlink:href="http://www.metahit.eu/" xlink:type="simple">http://www.metahit.eu/</uri>.</p>
</fn>
<fn id="fn5">
<p><sup>5</sup><uri xlink:href="http://www.hmpdacc.org" xlink:type="simple">http://www.hmpdacc.org</uri>.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ortega y Gasset</surname><given-names>J</given-names></name></person-group>
<source/>Meditaciones del Quijote. Ideas sobre la novela. <edition>3rd ed</edition>
<publisher-loc>Madrid</publisher-loc>: <publisher-name>Espasa-Calpe</publisher-name> (<year>1976</year>).</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkema</surname><given-names>W</given-names></name><name><surname>Boekhorst</surname><given-names>J</given-names></name><name><surname>Wels</surname><given-names>M</given-names></name><name><surname>van Hijum</surname><given-names>SA</given-names></name></person-group>. <article-title>Microbial bioinformatics for food safety and production</article-title>. <source/>Brief Bioinform (<year>2016</year>) <volume>17</volume>(<issue>2</issue>):<fpage>283</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1093/bib/bbv034</pub-id><pub-id pub-id-type="pmid">26082168</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benezra</surname><given-names>A</given-names></name><name><surname>DeStefano</surname><given-names>J</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group>. <article-title>Anthropology of microbes</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2012</year>) <volume>109</volume>(<issue>17</issue>):<fpage>6378</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1200515109</pub-id><pub-id pub-id-type="pmid">22460792</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Peterson</surname><given-names>DA</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group>. <article-title>Ecological and evolutionary forces shaping microbial diversity in the human intestine</article-title>. <source/>Cell (<year>2006</year>) <volume>124</volume>(<issue>4</issue>):<fpage>837</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2006.02.017</pub-id><pub-id pub-id-type="pmid">16497592</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Lozupone</surname><given-names>CA</given-names></name><name><surname>Hamady</surname><given-names>M</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group>. <article-title>Worlds within worlds: evolution of the vertebrate gut microbiota</article-title>. <source/>Nat Rev Microbiol (<year>2008</year>) <volume>6</volume>(<issue>10</issue>):<fpage>776</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro1978</pub-id><pub-id pub-id-type="pmid">18794915</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>I</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name></person-group>. <article-title>The human microbiome: at the interface of health and disease</article-title>. <source/>Nat Rev Genet (<year>2012</year>) <volume>13</volume>(<issue>4</issue>):<fpage>260</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1038/nrg3182</pub-id><pub-id pub-id-type="pmid">22411464</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>DC</given-names></name></person-group>
<article-title>Microbial ecology of the gastrointestinal tract</article-title>. <source/>Annu Rev Microbiol (<year>1977</year>) <volume>31</volume>:<fpage>107</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.mi.31.100177.000543</pub-id><pub-id pub-id-type="pmid">334036</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaser</surname><given-names>MJ</given-names></name><name><surname>Falkow</surname><given-names>S</given-names></name></person-group>. <article-title>What are the consequences of the disappearing human microbiota?</article-title>
<source/>Nat Rev Microbiol (<year>2009</year>) <volume>7</volume>(<issue>12</issue>):<fpage>887</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro2245</pub-id><pub-id pub-id-type="pmid">19898491</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco</surname><given-names>AR</given-names></name><name><surname>Sperandio</surname><given-names>V</given-names></name></person-group>
<article-title>Enteric pathogens exploit the microbiota-generated nutritional environment of the gut</article-title>. <source/>Microbiol Spectr (<year>2015</year>) <volume>3</volume>(<issue>3</issue>).<pub-id pub-id-type="doi">10.1128/microbiolspec.MBP-0001-2014</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>GB</given-names></name><name><surname>Keating</surname><given-names>DJ</given-names></name><name><surname>Young</surname><given-names>RL</given-names></name><name><surname>Wong</surname><given-names>ML</given-names></name><name><surname>Licinio</surname><given-names>J</given-names></name><name><surname>Wesselingh</surname><given-names>S</given-names></name></person-group>. <article-title>From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways</article-title>. <source/>Mol Psychiatry (<year>2016</year>) <volume>21</volume>(<issue>6</issue>):<fpage>738</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1038/mp.2016.50</pub-id><pub-id pub-id-type="pmid">27090305</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>SM</given-names></name><name><surname>Bercik</surname><given-names>P</given-names></name></person-group>. <article-title>The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease</article-title>. <source/>Gastroenterology (<year>2009</year>) <volume>136</volume>(<issue>6</issue>):<fpage>2003</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2009.01.075</pub-id><pub-id pub-id-type="pmid">19457424</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharon</surname><given-names>G</given-names></name><name><surname>Sampson</surname><given-names>TR</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Mazmanian</surname><given-names>SK</given-names></name></person-group>. <article-title>The central nervous system and the gut microbiome</article-title>. <source/>Cell (<year>2016</year>) <volume>167</volume>(<issue>4</issue>):<fpage>915</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2016.10.027</pub-id><pub-id pub-id-type="pmid">27814521</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>LV</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group>. <article-title>Commensal host-bacterial relationships in the gut</article-title>. <source/>Science (<year>2001</year>) <volume>292</volume>(<issue>5519</issue>):<fpage>1115</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1126/science.1058709</pub-id><pub-id pub-id-type="pmid">11352068</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pflughoeft</surname><given-names>KJ</given-names></name><name><surname>Versalovic</surname><given-names>J</given-names></name></person-group>. <article-title>Human microbiome in health and disease</article-title>. <source/>Annu Rev Pathol (<year>2012</year>) <volume>7</volume>:<fpage>99</fpage>–<lpage>122</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-pathol-011811-132421</pub-id><pub-id pub-id-type="pmid">21910623</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Backhed</surname><given-names>F</given-names></name><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Sonnenburg</surname><given-names>JL</given-names></name><name><surname>Peterson</surname><given-names>DA</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group>. <article-title>Host-bacterial mutualism in the human intestine</article-title>. <source/>Science (<year>2005</year>) <volume>307</volume>(<issue>5717</issue>):<fpage>1915</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1126/science.1104816</pub-id><pub-id pub-id-type="pmid">15790844</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>SM</given-names></name><name><surname>Surette</surname><given-names>M</given-names></name><name><surname>Bercik</surname><given-names>P</given-names></name></person-group>
<article-title>The interplay between the intestinal microbiota and the brain</article-title>. <source/>Nat Rev Microbiol (<year>2012</year>) <volume>10</volume>(<issue>11</issue>):<fpage>735</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro2876</pub-id><pub-id pub-id-type="pmid">23000955</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Raes</surname><given-names>J</given-names></name><name><surname>Arumugam</surname><given-names>M</given-names></name><name><surname>Burgdorf</surname><given-names>KS</given-names></name><name><surname>Manichanh</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>A human gut microbial gene catalogue established by metagenomic sequencing</article-title>. <source/>Nature (<year>2010</year>) <volume>464</volume>(<issue>7285</issue>):<fpage>59</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1038/nature08821</pub-id><pub-id pub-id-type="pmid">20203603</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jandhyala</surname><given-names>SM</given-names></name><name><surname>Talukdar</surname><given-names>R</given-names></name><name><surname>Subramanyam</surname><given-names>C</given-names></name><name><surname>Vuyyuru</surname><given-names>H</given-names></name><name><surname>Sasikala</surname><given-names>M</given-names></name><name><surname>Nageshwar Reddy</surname><given-names>D</given-names></name></person-group>. <article-title>Role of the normal gut microbiota</article-title>. <source/>World J Gastroenterol (<year>2015</year>) <volume>21</volume>(<issue>29</issue>):<fpage>8787</fpage>–<lpage>803</lpage>.<pub-id pub-id-type="doi">10.3748/wjg.v21.i29.8787</pub-id><pub-id pub-id-type="pmid">26269668</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fetissov</surname><given-names>SO</given-names></name></person-group>. <article-title>Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour</article-title>. <source/>Nat Rev Endocrinol (<year>2017</year>) <volume>13</volume>(<issue>1</issue>):<fpage>11</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1038/nrendo.2016.150</pub-id><pub-id pub-id-type="pmid">27616451</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elson</surname><given-names>CO</given-names></name><name><surname>Alexander</surname><given-names>KL</given-names></name></person-group>. <article-title>Host-microbiota interactions in the intestine</article-title>. <source/>Dig Dis (<year>2015</year>) <volume>33</volume>(<issue>2</issue>):<fpage>131</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1159/000369534</pub-id><pub-id pub-id-type="pmid">25925913</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wlodarska</surname><given-names>M</given-names></name><name><surname>Kostic</surname><given-names>AD</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name></person-group>. <article-title>An integrative view of microbiome-host interactions in inflammatory bowel diseases</article-title>. <source/>Cell Host Microbe (<year>2015</year>) <volume>17</volume>(<issue>5</issue>):<fpage>577</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2015.04.008</pub-id><pub-id pub-id-type="pmid">25974300</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacka</surname><given-names>FN</given-names></name></person-group>
<article-title>Nutritional psychiatry: where to next?</article-title>
<source/>EBioMedicine (<year>2017</year>) <volume>17</volume>:<fpage>24</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.ebiom.2017.02.020</pub-id><pub-id pub-id-type="pmid">28242200</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freter</surname><given-names>R</given-names></name><name><surname>Brickner</surname><given-names>H</given-names></name><name><surname>Botney</surname><given-names>M</given-names></name><name><surname>Cleven</surname><given-names>D</given-names></name><name><surname>Aranki</surname><given-names>A</given-names></name></person-group>. <article-title>Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora</article-title>. <source/>Infect Immun (<year>1983</year>) <volume>39</volume>(<issue>2</issue>):<fpage>676</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">6339388</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gesch</surname><given-names>CB</given-names></name><name><surname>Hammond</surname><given-names>SM</given-names></name><name><surname>Hampson</surname><given-names>SE</given-names></name><name><surname>Eves</surname><given-names>A</given-names></name><name><surname>Crowder</surname><given-names>MJ</given-names></name></person-group>
<article-title>Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial</article-title>. <source/>Br J Psychiatry (<year>2002</year>) <volume>181</volume>:<fpage>22</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1192/bjp.181.1.22</pub-id><pub-id pub-id-type="pmid">12091259</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cenit</surname><given-names>MC</given-names></name><name><surname>Matzaraki</surname><given-names>V</given-names></name><name><surname>Tigchelaar</surname><given-names>EF</given-names></name><name><surname>Zhernakova</surname><given-names>A</given-names></name></person-group>. <article-title>Rapidly expanding knowledge on the role of the gut microbiome in health and disease</article-title>. <source/>Biochim Biophys Acta (<year>2014</year>) <volume>1842</volume>(<issue>10</issue>):<fpage>1981</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbadis.2014.05.023</pub-id><pub-id pub-id-type="pmid">24882755</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremlett</surname><given-names>H</given-names></name><name><surname>Bauer</surname><given-names>KC</given-names></name><name><surname>Appel-Cresswell</surname><given-names>S</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name><name><surname>Waubant</surname><given-names>E</given-names></name></person-group>. <article-title>The gut microbiome in human neurological disease: a review</article-title>. <source/>Ann Neurol (<year>2017</year>) <volume>81</volume>:<fpage>369</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1002/ana.24901</pub-id><pub-id pub-id-type="pmid">28220542</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colpitts</surname><given-names>SL</given-names></name><name><surname>Kasper</surname><given-names>LH</given-names></name></person-group>. <article-title>Influence of the gut microbiome on autoimmunity in the central nervous system</article-title>. <source/>J Immunol (<year>2017</year>) <volume>198</volume>(<issue>2</issue>):<fpage>596</fpage>–<lpage>604</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1601438</pub-id><pub-id pub-id-type="pmid">28069755</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tognini</surname><given-names>P</given-names></name></person-group>. <article-title>Gut microbiota: a potential regulator of neurodevelopment</article-title>. <source/>Front Cell Neurosci (<year>2017</year>) <volume>11</volume>:<fpage>25</fpage>.<pub-id pub-id-type="doi">10.3389/fncel.2017.00025</pub-id><pub-id pub-id-type="pmid">28223922</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckburg</surname><given-names>PB</given-names></name><name><surname>Bik</surname><given-names>EM</given-names></name><name><surname>Bernstein</surname><given-names>CN</given-names></name><name><surname>Purdom</surname><given-names>E</given-names></name><name><surname>Dethlefsen</surname><given-names>L</given-names></name><name><surname>Sargent</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Diversity of the human intestinal microbial flora</article-title>. <source/>Science (<year>2005</year>) <volume>308</volume>(<issue>5728</issue>):<fpage>1635</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1126/science.1110591</pub-id><pub-id pub-id-type="pmid">15831718</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matamoros</surname><given-names>S</given-names></name><name><surname>Gras-Leguen</surname><given-names>C</given-names></name><name><surname>Le Vacon</surname><given-names>F</given-names></name><name><surname>Potel</surname><given-names>G</given-names></name><name><surname>de La Cochetiere</surname><given-names>MF</given-names></name></person-group>. <article-title>Development of intestinal microbiota in infants and its impact on health</article-title>. <source/>Trends Microbiol (<year>2013</year>) <volume>21</volume>(<issue>4</issue>):<fpage>167</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1016/j.tim.2012.12.001</pub-id><pub-id pub-id-type="pmid">23332725</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aroniadis</surname><given-names>OC</given-names></name><name><surname>Drossman</surname><given-names>DA</given-names></name><name><surname>Simren</surname><given-names>M</given-names></name></person-group>. <article-title>A perspective on brain-gut communication: the American Gastroenterology Association and American Psychosomatic Society joint symposium on brain-gut interactions and the intestinal microenvironment</article-title>. <source/>Psychosom Med (<year>2017</year>).<pub-id pub-id-type="doi">10.1097/PSY.0000000000000431</pub-id><pub-id pub-id-type="pmid">27922565</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>H</given-names></name><name><surname>Nakazato</surname><given-names>M</given-names></name></person-group>. <article-title>Mechanistic relationship between the vagal afferent pathway, central nervous system and peripheral organs in appetite regulation</article-title>. <source/>J Diabetes Investig (<year>2016</year>) <volume>7</volume>(<issue>6</issue>):<fpage>812</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/jdi.12492</pub-id><pub-id pub-id-type="pmid">27180615</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berthoud</surname><given-names>HR</given-names></name></person-group>. <article-title>The vagus nerve, food intake and obesity</article-title>. <source/>Regul Pept (<year>2008</year>) <volume>149</volume>(<issue>1–3</issue>):<fpage>15</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1016/j.regpep.2007.08.024</pub-id><pub-id pub-id-type="pmid">18482776</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berthoud</surname><given-names>HR</given-names></name><name><surname>Neuhuber</surname><given-names>WL</given-names></name></person-group>
<article-title>Functional and chemical anatomy of the afferent vagal system</article-title>. <source/>Auton Neurosci (<year>2000</year>) <volume>85</volume>(<issue>1–3</issue>):<fpage>1</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1016/S1566-0702(00)00215-0</pub-id><pub-id pub-id-type="pmid">11189015</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>PV</given-names></name><name><surname>Hamr</surname><given-names>SC</given-names></name><name><surname>Duca</surname><given-names>FA</given-names></name></person-group>. <article-title>Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota</article-title>. <source/>Cell Mol Life Sci (<year>2016</year>) <volume>73</volume>(<issue>4</issue>):<fpage>737</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1007/s00018-015-2083-z</pub-id><pub-id pub-id-type="pmid">26542800</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chronwall</surname><given-names>BM</given-names></name></person-group>. <article-title>Anatomy and physiology of the neuroendocrine arcuate nucleus</article-title>. <source/>Peptides (<year>1985</year>) <volume>6</volume>(<issue>Suppl 2</issue>):<fpage>1</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1016/0196-9781(85)90128-7</pub-id><pub-id pub-id-type="pmid">2417205</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vuong</surname><given-names>HE</given-names></name><name><surname>Yano</surname><given-names>JM</given-names></name><name><surname>Fung</surname><given-names>TC</given-names></name><name><surname>Hsiao</surname><given-names>EY</given-names></name></person-group>
<article-title>The microbiome and host behavior</article-title>. <source/>Annu Rev Neurosci (<year>2017</year>) <volume>40</volume>:<fpage>21</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-neuro-072116-031347</pub-id><pub-id pub-id-type="pmid">28301775</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name></person-group>. <article-title>Gut microbiota: the brain peacekeeper</article-title>. <source/>Front Microbiol (<year>2016</year>) <volume>7</volume>:<fpage>345</fpage>.<pub-id pub-id-type="doi">10.3389/fmicb.2016.00345</pub-id><pub-id pub-id-type="pmid">27014255</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudo</surname><given-names>N</given-names></name><name><surname>Chida</surname><given-names>Y</given-names></name><name><surname>Aiba</surname><given-names>Y</given-names></name><name><surname>Sonoda</surname><given-names>J</given-names></name><name><surname>Oyama</surname><given-names>N</given-names></name><name><surname>Yu</surname><given-names>XN</given-names></name><etal></etal></person-group>
<article-title>Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice</article-title>. <source/>J Physiol (<year>2004</year>) <volume>558</volume>(<issue>Pt 1</issue>):<fpage>263</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1113/jphysiol.2004.063388</pub-id><pub-id pub-id-type="pmid">15133062</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borrelli</surname><given-names>L</given-names></name><name><surname>Aceto</surname><given-names>S</given-names></name><name><surname>Agnisola</surname><given-names>C</given-names></name><name><surname>De Paolo</surname><given-names>S</given-names></name><name><surname>Dipineto</surname><given-names>L</given-names></name><name><surname>Stilling</surname><given-names>RM</given-names></name><etal></etal></person-group>
<article-title>Probiotic modulation of the microbiota-gut-brain axis and behaviour in zebrafish</article-title>. <source/>Sci Rep (<year>2016</year>) <volume>6</volume>:<fpage>30046</fpage>.<pub-id pub-id-type="doi">10.1038/srep30046</pub-id><pub-id pub-id-type="pmid">27416816</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDermott</surname><given-names>AJ</given-names></name><name><surname>Huffnagle</surname><given-names>GB</given-names></name></person-group>. <article-title>The microbiome and regulation of mucosal immunity</article-title>. <source/>Immunology (<year>2014</year>) <volume>142</volume>(<issue>1</issue>):<fpage>24</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1111/imm.12231</pub-id><pub-id pub-id-type="pmid">24329495</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rea</surname><given-names>K</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>. <article-title>The microbiome: a key regulator of stress and neuroinflammation</article-title>. <source/>Neurobiol Stress (<year>2016</year>) <volume>4</volume>:<fpage>23</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1016/j.ynstr.2016.03.001</pub-id><pub-id pub-id-type="pmid">27981187</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>JR</given-names></name><name><surname>Kennedy</surname><given-names>PJ</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Hyland</surname><given-names>NP</given-names></name></person-group>. <article-title>Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders</article-title>. <source/>Front Cell Neurosci (<year>2015</year>) <volume>9</volume>:<fpage>392</fpage>.<pub-id pub-id-type="doi">10.3389/fncel.2015.00392</pub-id><pub-id pub-id-type="pmid">26528128</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>YB</given-names></name><name><surname>Li</surname><given-names>YQ</given-names></name></person-group>. <article-title>Enteric glial cells and their role in the intestinal epithelial barrier</article-title>. <source/>World J Gastroenterol (<year>2014</year>) <volume>20</volume>(<issue>32</issue>):<fpage>11273</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="doi">10.3748/wjg.v20.i32.11273</pub-id><pub-id pub-id-type="pmid">25170211</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Mahony</surname><given-names>SM</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Borre</surname><given-names>YE</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>. <article-title>Serotonin, tryptophan metabolism and the brain-gut-microbiome axis</article-title>. <source/>Behav Brain Res (<year>2015</year>) <volume>277</volume>:<fpage>32</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbr.2014.07.027</pub-id><pub-id pub-id-type="pmid">25078296</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hullar</surname><given-names>MA</given-names></name><name><surname>Fu</surname><given-names>BC</given-names></name></person-group>
<article-title>Diet, the gut microbiome, and epigenetics</article-title>. <source/>Cancer J (<year>2014</year>) <volume>20</volume>(<issue>3</issue>):<fpage>170</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1097/PPO.0000000000000053</pub-id><pub-id pub-id-type="pmid">24855003</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roh</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name></person-group>
<article-title>Brain regulation of energy metabolism</article-title>. <source/>Endocrinol Metab (<year>2016</year>) <volume>31</volume>(<issue>4</issue>):<fpage>519</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.3803/EnM.2016.31.4.519</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konner</surname><given-names>AC</given-names></name><name><surname>Klockener</surname><given-names>T</given-names></name><name><surname>Bruning</surname><given-names>JC</given-names></name></person-group>. <article-title>Control of energy homeostasis by insulin and leptin: targeting the arcuate nucleus and beyond</article-title>. <source/>Physiol Behav (<year>2009</year>) <volume>97</volume>(<issue>5</issue>):<fpage>632</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.physbeh.2009.03.027</pub-id><pub-id pub-id-type="pmid">19351541</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowley</surname><given-names>MA</given-names></name><name><surname>Smart</surname><given-names>JL</given-names></name><name><surname>Rubinstein</surname><given-names>M</given-names></name><name><surname>Cerdan</surname><given-names>MG</given-names></name><name><surname>Diano</surname><given-names>S</given-names></name><name><surname>Horvath</surname><given-names>TL</given-names></name><etal></etal></person-group>
<article-title>Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus</article-title>. <source/>Nature (<year>2001</year>) <volume>411</volume>(<issue>6836</issue>):<fpage>480</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1038/35078085</pub-id><pub-id pub-id-type="pmid">11373681</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>CC</given-names></name><name><surname>Clifton</surname><given-names>DK</given-names></name><name><surname>Steiner</surname><given-names>RA</given-names></name></person-group>. <article-title>Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus</article-title>. <source/>Endocrinology (<year>1997</year>) <volume>138</volume>(<issue>10</issue>):<fpage>4489</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1210/endo.138.10.5570</pub-id><pub-id pub-id-type="pmid">9322969</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aagaard</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Antony</surname><given-names>KM</given-names></name><name><surname>Ganu</surname><given-names>R</given-names></name><name><surname>Petrosino</surname><given-names>J</given-names></name><name><surname>Versalovic</surname><given-names>J</given-names></name></person-group>. <article-title>The placenta harbors a unique microbiome</article-title>. <source/>Sci Transl Med (<year>2014</year>) <volume>6</volume>(<issue>237</issue>):<fpage>237ra65</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.3008599</pub-id><pub-id pub-id-type="pmid">24848255</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collado</surname><given-names>MC</given-names></name><name><surname>Rautava</surname><given-names>S</given-names></name><name><surname>Aakko</surname><given-names>J</given-names></name><name><surname>Isolauri</surname><given-names>E</given-names></name><name><surname>Salminen</surname><given-names>S</given-names></name></person-group>. <article-title>Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid</article-title>. <source/>Sci Rep (<year>2016</year>) <volume>6</volume>:<fpage>23129</fpage>.<pub-id pub-id-type="doi">10.1038/srep23129</pub-id><pub-id pub-id-type="pmid">27001291</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jimenez</surname><given-names>E</given-names></name><name><surname>Marin</surname><given-names>ML</given-names></name><name><surname>Martin</surname><given-names>R</given-names></name><name><surname>Odriozola</surname><given-names>JM</given-names></name><name><surname>Olivares</surname><given-names>M</given-names></name><name><surname>Xaus</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Is meconium from healthy newborns actually sterile?</article-title>
<source/>Res Microbiol (<year>2008</year>) <volume>159</volume>(<issue>3</issue>):<fpage>187</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1016/j.resmic.2007.12.007</pub-id><pub-id pub-id-type="pmid">18281199</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Poo</surname><given-names>MM</given-names></name></person-group>. <article-title>Neurotrophin regulation of neural circuit development and function</article-title>. <source/>Nat Rev Neurosci (<year>2013</year>) <volume>14</volume>(<issue>1</issue>):<fpage>7</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1038/nrn3379</pub-id><pub-id pub-id-type="pmid">23254191</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krautkramer</surname><given-names>KA</given-names></name><name><surname>Rey</surname><given-names>FE</given-names></name><name><surname>Denu</surname><given-names>JM</given-names></name></person-group>. <article-title>Chemical signaling between gut microbiota and host chromatin: what is your gut really saying?</article-title>
<source/>J Biol Chem (<year>2017</year>) <volume>292</volume>:<fpage>8582</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.R116.761577</pub-id><pub-id pub-id-type="pmid">28389558</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luczynski</surname><given-names>P</given-names></name><name><surname>Whelan</surname><given-names>SO</given-names></name><name><surname>O’Sullivan</surname><given-names>C</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><etal></etal></person-group>
<article-title>Adult microbiota-deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus</article-title>. <source/>Eur J Neurosci (<year>2016</year>) <volume>44</volume>(<issue>9</issue>):<fpage>2654</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1111/ejn.13291</pub-id><pub-id pub-id-type="pmid">27256072</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>RK</given-names></name><name><surname>Mulberg</surname><given-names>AE</given-names></name><name><surname>Grand</surname><given-names>RJ</given-names></name></person-group>. <article-title>Development of the human gastrointestinal tract: twenty years of progress</article-title>. <source/>Gastroenterology (<year>1999</year>) <volume>116</volume>(<issue>3</issue>):<fpage>702</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1016/S0016-5085(99)70193-9</pub-id><pub-id pub-id-type="pmid">10029630</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabouridis</surname><given-names>PS</given-names></name><name><surname>Pachnis</surname><given-names>V</given-names></name></person-group>. <article-title>Emerging roles of gut microbiota and the immune system in the development of the enteric nervous system</article-title>. <source/>J Clin Invest (<year>2015</year>) <volume>125</volume>(<issue>3</issue>):<fpage>956</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1172/JCI76308</pub-id><pub-id pub-id-type="pmid">25729852</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhasselt</surname><given-names>V</given-names></name></person-group>. <article-title>Neonatal tolerance under breastfeeding influence: the presence of allergen and transforming growth factor-beta in breast milk protects the progeny from allergic asthma</article-title>. <source/>J Pediatr (<year>2010</year>) <volume>156</volume>(<issue>2 Suppl</issue>):<fpage>S16</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpeds.2009.11.015</pub-id><pub-id pub-id-type="pmid">20105659</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchesi</surname><given-names>JR</given-names></name><name><surname>Adams</surname><given-names>DH</given-names></name><name><surname>Fava</surname><given-names>F</given-names></name><name><surname>Hermes</surname><given-names>GD</given-names></name><name><surname>Hirschfield</surname><given-names>GM</given-names></name><name><surname>Hold</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>The gut microbiota and host health: a new clinical frontier</article-title>. <source/>Gut (<year>2016</year>) <volume>65</volume>(<issue>2</issue>):<fpage>330</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1136/gutjnl-2015-309990</pub-id><pub-id pub-id-type="pmid">26338727</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lennon</surname><given-names>EM</given-names></name><name><surname>Maharshak</surname><given-names>N</given-names></name><name><surname>Elloumi</surname><given-names>H</given-names></name><name><surname>Borst</surname><given-names>L</given-names></name><name><surname>Plevy</surname><given-names>SE</given-names></name><name><surname>Moeser</surname><given-names>AJ</given-names></name></person-group>. <article-title>Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10-/- mice</article-title>. <source/>Inflamm Bowel Dis (<year>2013</year>) <volume>19</volume>(<issue>4</issue>):<fpage>712</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1097/MIB.0b013e3182802a4e</pub-id><pub-id pub-id-type="pmid">23446335</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naseribafrouei</surname><given-names>A</given-names></name><name><surname>Hestad</surname><given-names>K</given-names></name><name><surname>Avershina</surname><given-names>E</given-names></name><name><surname>Sekelja</surname><given-names>M</given-names></name><name><surname>Linlokken</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Correlation between the human fecal microbiota and depression</article-title>. <source/>Neurogastroenterol Motil (<year>2014</year>) <volume>26</volume>(<issue>8</issue>):<fpage>1155</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1111/nmo.12378</pub-id><pub-id pub-id-type="pmid">24888394</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Ling</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Altered fecal microbiota composition in patients with major depressive disorder</article-title>. <source/>Brain Behav Immun (<year>2015</year>) <volume>48</volume>:<fpage>186</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2015.03.016</pub-id><pub-id pub-id-type="pmid">25882912</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lima-Ojeda</surname><given-names>JM</given-names></name></person-group>
<source/>Neurodevelopment and Schizophrenia: Pharmacological and Behavioral Animal Models [Doctoral Thesis]. <publisher-loc>Mannheim</publisher-loc>: <publisher-name>Ruperto Carola University of Heidelberg</publisher-name> (<year>2014</year>).</mixed-citation>
</ref>
<ref id="B65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima-Ojeda</surname><given-names>JM</given-names></name><name><surname>Rupprecht</surname><given-names>R</given-names></name><name><surname>Baghai</surname><given-names>TC</given-names></name></person-group>
<article-title>Neurobiology of depression: a neurodevelopmental approach</article-title>. <source/>World J Biol Psychiatry (<year>2017</year>) <volume>3</volume>:<fpage>1</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1080/15622975.2017.1289240</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semple</surname><given-names>BD</given-names></name><name><surname>Blomgren</surname><given-names>K</given-names></name><name><surname>Gimlin</surname><given-names>K</given-names></name><name><surname>Ferriero</surname><given-names>DM</given-names></name><name><surname>Noble-Haeusslein</surname><given-names>LJ</given-names></name></person-group>. <article-title>Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species</article-title>. <source/>Prog Neurobiol (<year>2013</year>) <volume>106-107</volume>:<fpage>1</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1016/j.pneurobio.2013.04.001</pub-id><pub-id pub-id-type="pmid">23583307</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volpe</surname><given-names>JJ</given-names></name></person-group>
<article-title>Overview: normal and abnormal human brain development</article-title>. <source/>Ment Retard Dev Disabil Res Rev (<year>2000</year>) <volume>6</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1002/(SICI)1098-2779(2000)6:1&lt;1:AID-MRDD1&gt;3.0.CO;2-J</pub-id><pub-id pub-id-type="pmid">10899791</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name></person-group>. <article-title>Biology and pathobiology of neuronal development</article-title>. <source/>Ment Retard Dev Disabil Res Rev (<year>2000</year>) <volume>6</volume>(<issue>1</issue>):<fpage>41</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1002/(SICI)1098-2779(2000)6:1&lt;41:AID-MRDD6&gt;3.0.CO;2-V</pub-id><pub-id pub-id-type="pmid">10899796</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casey</surname><given-names>BJ</given-names></name><name><surname>Giedd</surname><given-names>JN</given-names></name><name><surname>Thomas</surname><given-names>KM</given-names></name></person-group>. <article-title>Structural and functional brain development and its relation to cognitive development</article-title>. <source/>Biol Psychol (<year>2000</year>) <volume>54</volume>(<issue>1–3</issue>):<fpage>241</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1016/S0301-0511(00)00058-2</pub-id><pub-id pub-id-type="pmid">11035225</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>C</given-names></name><name><surname>Syddall</surname><given-names>H</given-names></name><name><surname>Rodin</surname><given-names>I</given-names></name><name><surname>Osmond</surname><given-names>C</given-names></name><name><surname>Barker</surname><given-names>DJ</given-names></name></person-group>
<article-title>Birth weight and the risk of depressive disorder in late life</article-title>. <source/>Br J Psychiatry (<year>2001</year>) <volume>179</volume>:<fpage>450</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1192/bjp.179.5.450</pub-id><pub-id pub-id-type="pmid">11689404</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bale</surname><given-names>TL</given-names></name><name><surname>Baram</surname><given-names>TZ</given-names></name><name><surname>Brown</surname><given-names>AS</given-names></name><name><surname>Goldstein</surname><given-names>JM</given-names></name><name><surname>Insel</surname><given-names>TR</given-names></name><name><surname>McCarthy</surname><given-names>MM</given-names></name><etal></etal></person-group>
<article-title>Early life programming and neurodevelopmental disorders</article-title>. <source/>Biol Psychiatry (<year>2010</year>) <volume>68</volume>(<issue>4</issue>):<fpage>314</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.05.028</pub-id><pub-id pub-id-type="pmid">20674602</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nanni</surname><given-names>V</given-names></name><name><surname>Uher</surname><given-names>R</given-names></name><name><surname>Danese</surname><given-names>A</given-names></name></person-group>. <article-title>Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis</article-title>. <source/>Am J Psychiatry (<year>2012</year>) <volume>169</volume>(<issue>2</issue>):<fpage>141</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1176/appi.ajp.2011.11020335</pub-id><pub-id pub-id-type="pmid">22420036</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handel</surname><given-names>AE</given-names></name><name><surname>Ebers</surname><given-names>GC</given-names></name><name><surname>Ramagopalan</surname><given-names>SV</given-names></name></person-group>
<article-title>Epigenetics: molecular mechanisms and implications for disease</article-title>. <source/>Trends Mol Med (<year>2010</year>) <volume>16</volume>(<issue>1</issue>):<fpage>7</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1016/j.molmed.2009.11.003</pub-id><pub-id pub-id-type="pmid">20022812</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murgatroyd</surname><given-names>C</given-names></name><name><surname>Spengler</surname><given-names>D</given-names></name></person-group>. <article-title>Epigenetics of early child development</article-title>. <source/>Front Psychiatry (<year>2011</year>) <volume>2</volume>:<fpage>16</fpage>.<pub-id pub-id-type="doi">10.3389/fpsyt.2011.00016</pub-id><pub-id pub-id-type="pmid">21647402</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levinson</surname><given-names>DF</given-names></name></person-group>. <article-title>The genetics of depression: a review</article-title>. <source/>Biol Psychiatry (<year>2006</year>) <volume>60</volume>(<issue>2</issue>):<fpage>84</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2005.08.024</pub-id><pub-id pub-id-type="pmid">16300747</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopizzo</surname><given-names>N</given-names></name><name><surname>Bocchio Chiavetto</surname><given-names>L</given-names></name><name><surname>Cattane</surname><given-names>N</given-names></name><name><surname>Plazzotta</surname><given-names>G</given-names></name><name><surname>Tarazi</surname><given-names>FI</given-names></name><name><surname>Pariante</surname><given-names>CM</given-names></name><etal></etal></person-group>
<article-title>Gene-environment interaction in major depression: focus on experience-dependent biological systems</article-title>. <source/>Front Psychiatry (<year>2015</year>) <volume>6</volume>:<fpage>68</fpage>.<pub-id pub-id-type="doi">10.3389/fpsyt.2015.00068</pub-id><pub-id pub-id-type="pmid">26005424</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>WT</given-names></name><name><surname>LaSalle</surname><given-names>JM</given-names></name></person-group>. <article-title>Epigenetic mechanisms in diurnal cycles of metabolism and neurodevelopment</article-title>. <source/>Hum Mol Genet (<year>2015</year>) <volume>24</volume>(<issue>R1</issue>):<fpage>R1</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1093/hmg/ddv234</pub-id><pub-id pub-id-type="pmid">26105183</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Essex</surname><given-names>MJ</given-names></name><name><surname>Boyce</surname><given-names>WT</given-names></name><name><surname>Hertzman</surname><given-names>C</given-names></name><name><surname>Lam</surname><given-names>LL</given-names></name><name><surname>Armstrong</surname><given-names>JM</given-names></name><name><surname>Neumann</surname><given-names>SM</given-names></name><etal></etal></person-group>
<article-title>Epigenetic vestiges of early developmental adversity: childhood stress exposure and DNA methylation in adolescence</article-title>. <source/>Child Dev (<year>2013</year>) <volume>84</volume>(<issue>1</issue>):<fpage>58</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1111/j.1467-8624.2011.01641.x</pub-id><pub-id pub-id-type="pmid">21883162</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundakovic</surname><given-names>M</given-names></name><name><surname>Gudsnuk</surname><given-names>K</given-names></name><name><surname>Herbstman</surname><given-names>JB</given-names></name><name><surname>Tang</surname><given-names>D</given-names></name><name><surname>Perera</surname><given-names>FP</given-names></name><name><surname>Champagne</surname><given-names>FA</given-names></name></person-group>
<article-title>DNA methylation of BDNF as a biomarker of early-life adversity</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2015</year>) <volume>112</volume>(<issue>22</issue>):<fpage>6807</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1408355111</pub-id><pub-id pub-id-type="pmid">25385582</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booij</surname><given-names>L</given-names></name><name><surname>Szyf</surname><given-names>M</given-names></name><name><surname>Carballedo</surname><given-names>A</given-names></name><name><surname>Frey</surname><given-names>EM</given-names></name><name><surname>Morris</surname><given-names>D</given-names></name><name><surname>Dymov</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls</article-title>. <source/>PLoS One (<year>2015</year>) <volume>10</volume>(<issue>3</issue>):<fpage>e0119061</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0119061</pub-id><pub-id pub-id-type="pmid">25781010</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brambilla</surname><given-names>F</given-names></name></person-group>. <article-title>Psychoneurendocrinology: a science of the past or a new pathway for the future?</article-title>
<source/>Eur J Pharmacol (<year>2000</year>) <volume>405</volume>(<issue>1–3</issue>):<fpage>341</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/S0014-2999(00)00564-1</pub-id><pub-id pub-id-type="pmid">11033339</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dantzer</surname><given-names>R</given-names></name><name><surname>O’Connor</surname><given-names>JC</given-names></name><name><surname>Freund</surname><given-names>GG</given-names></name><name><surname>Johnson</surname><given-names>RW</given-names></name><name><surname>Kelley</surname><given-names>KW</given-names></name></person-group>. <article-title>From inflammation to sickness and depression: when the immune system subjugates the brain</article-title>. <source/>Nat Rev Neurosci (<year>2008</year>) <volume>9</volume>(<issue>1</issue>):<fpage>46</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1038/nrn2297</pub-id><pub-id pub-id-type="pmid">18073775</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilbo</surname><given-names>SD</given-names></name><name><surname>Schwarz</surname><given-names>JM</given-names></name></person-group>. <article-title>The immune system and developmental programming of brain and behavior</article-title>. <source/>Front Neuroendocrinol (<year>2012</year>) <volume>33</volume>(<issue>3</issue>):<fpage>267</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1016/j.yfrne.2012.08.006</pub-id><pub-id pub-id-type="pmid">22982535</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massart</surname><given-names>R</given-names></name><name><surname>Mongeau</surname><given-names>R</given-names></name><name><surname>Lanfumey</surname><given-names>L</given-names></name></person-group>. <article-title>Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression</article-title>. <source/>Philos Trans R Soc Lond B Biol Sci (<year>2012</year>) <volume>367</volume>(<issue>1601</issue>):<fpage>2485</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1098/rstb.2012.0212</pub-id><pub-id pub-id-type="pmid">22826347</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>J</given-names></name><name><surname>Costafreda</surname><given-names>SG</given-names></name><name><surname>McGuffin</surname><given-names>P</given-names></name><name><surname>Fu</surname><given-names>CH</given-names></name></person-group>. <article-title>Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies</article-title>. <source/>J Affect Disord (<year>2011</year>) <volume>134</volume>(<issue>1–3</issue>):<fpage>483</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.jad.2011.05.057</pub-id><pub-id pub-id-type="pmid">21745692</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>JP</given-names></name><name><surname>Siemer</surname><given-names>M</given-names></name><name><surname>Gotlib</surname><given-names>IH</given-names></name></person-group>. <article-title>Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies</article-title>. <source/>Mol Psychiatry (<year>2008</year>) <volume>13</volume>(<issue>11</issue>):<fpage>993</fpage>–<lpage>1000</lpage>.<pub-id pub-id-type="doi">10.1038/mp.2008.57</pub-id><pub-id pub-id-type="pmid">18504424</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fava</surname><given-names>GA</given-names></name><name><surname>Grandi</surname><given-names>S</given-names></name><name><surname>Canestrari</surname><given-names>R</given-names></name><name><surname>Molnar</surname><given-names>G</given-names></name></person-group>. <article-title>Prodromal symptoms in primary major depressive disorder</article-title>. <source/>J Affect Disord (<year>1990</year>) <volume>19</volume>(<issue>2</issue>):<fpage>149</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1016/0165-0327(90)90020-9</pub-id><pub-id pub-id-type="pmid">2142701</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Judd</surname><given-names>LL</given-names></name><name><surname>Akiskal</surname><given-names>HS</given-names></name><name><surname>Paulus</surname><given-names>MP</given-names></name></person-group>
<article-title>The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder</article-title>. <source/>J Affect Disord (<year>1997</year>) <volume>45</volume>(<issue>1–2</issue>):<fpage>5</fpage>–<lpage>17; discussion 17–8</lpage>.<pub-id pub-id-type="doi">10.1016/S0165-0327(97)00055-4</pub-id><pub-id pub-id-type="pmid">9268771</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>A</given-names></name><name><surname>Cavanagh</surname><given-names>J</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name></person-group>. <article-title>A systematic review of manic and depressive prodromes</article-title>. <source/>J Affect Disord (<year>2003</year>) <volume>74</volume>(<issue>3</issue>):<fpage>209</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1016/S0165-0327(02)00266-5</pub-id><pub-id pub-id-type="pmid">12738039</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skjelstad</surname><given-names>DV</given-names></name><name><surname>Malt</surname><given-names>UF</given-names></name><name><surname>Holte</surname><given-names>A</given-names></name></person-group>. <article-title>Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review</article-title>. <source/>J Affect Disord (<year>2010</year>) <volume>126</volume>(<issue>1–2</issue>):<fpage>1</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1016/j.jad.2009.10.003</pub-id><pub-id pub-id-type="pmid">19883943</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tenyi</surname><given-names>T</given-names></name><name><surname>Trixler</surname><given-names>M</given-names></name><name><surname>Csabi</surname><given-names>G</given-names></name></person-group>. <article-title>Minor physical anomalies in affective disorders. A review of the literature</article-title>. <source/>J Affect Disord (<year>2009</year>) <volume>112</volume>(<issue>1–3</issue>):<fpage>11</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.jad.2008.04.025</pub-id><pub-id pub-id-type="pmid">18508129</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>JA</given-names></name><name><surname>McVey Neufeld</surname><given-names>KA</given-names></name></person-group>
<article-title>Gut-brain axis: how the microbiome influences anxiety and depression</article-title>. <source/>Trends Neurosci (<year>2013</year>) <volume>36</volume>(<issue>5</issue>):<fpage>305</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1016/j.tins.2013.01.005</pub-id><pub-id pub-id-type="pmid">23384445</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Theije</surname><given-names>CG</given-names></name><name><surname>Wopereis</surname><given-names>H</given-names></name><name><surname>Ramadan</surname><given-names>M</given-names></name><name><surname>van Eijndthoven</surname><given-names>T</given-names></name><name><surname>Lambert</surname><given-names>J</given-names></name><name><surname>Knol</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Altered gut microbiota and activity in a murine model of autism spectrum disorders</article-title>. <source/>Brain Behav Immun (<year>2014</year>) <volume>37</volume>:<fpage>197</fpage>–<lpage>206</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbi.2013.12.005</pub-id><pub-id pub-id-type="pmid">24333160</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz Heijtz</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Anuar</surname><given-names>F</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Bjorkholm</surname><given-names>B</given-names></name><name><surname>Samuelsson</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Normal gut microbiota modulates brain development and behavior</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2011</year>) <volume>108</volume>(<issue>7</issue>):<fpage>3047</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1010529108</pub-id><pub-id pub-id-type="pmid">21282636</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogbonnaya</surname><given-names>ES</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>O’Leary</surname><given-names>OF</given-names></name></person-group>
<article-title>Adult hippocampal neurogenesis is regulated by the microbiome</article-title>. <source/>Biol Psychiatry (<year>2015</year>) <volume>78</volume>(<issue>4</issue>):<fpage>e7</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.biopsych.2014.12.023</pub-id><pub-id pub-id-type="pmid">25700599</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borre</surname><given-names>YE</given-names></name><name><surname>O’Keeffe</surname><given-names>GW</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>. <article-title>Microbiota and neurodevelopmental windows: implications for brain disorders</article-title>. <source/>Trends Mol Med (<year>2014</year>) <volume>20</volume>(<issue>9</issue>):<fpage>509</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="doi">10.1016/j.molmed.2014.05.002</pub-id><pub-id pub-id-type="pmid">24956966</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilbo</surname><given-names>SD</given-names></name><name><surname>Frank</surname><given-names>A</given-names></name></person-group>
<article-title>Beach award: programming of neuroendocrine function by early-life experience: a critical role for the immune system</article-title>. <source/>Horm Behav (<year>2013</year>) <volume>63</volume>(<issue>5</issue>):<fpage>684</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.yhbeh.2013.02.017</pub-id><pub-id pub-id-type="pmid">23474365</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulanger</surname><given-names>LM</given-names></name></person-group>. <article-title>Immune proteins in brain development and synaptic plasticity</article-title>. <source/>Neuron (<year>2009</year>) <volume>64</volume>(<issue>1</issue>):<fpage>93</fpage>–<lpage>109</lpage>.<pub-id pub-id-type="doi">10.1016/j.neuron.2009.09.001</pub-id><pub-id pub-id-type="pmid">19840552</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>D</given-names></name><name><surname>Fernando</surname><given-names>P</given-names></name><name><surname>Cicvaric</surname><given-names>A</given-names></name><name><surname>Berger</surname><given-names>A</given-names></name><name><surname>Pollak</surname><given-names>A</given-names></name><name><surname>Monje</surname><given-names>FJ</given-names></name><etal></etal></person-group>
<article-title>Long-term effects of maternal immune activation on depression-like behavior in the mouse</article-title>. <source/>Transl Psychiatry (<year>2014</year>) <volume>4</volume>:<fpage>e363</fpage>.<pub-id pub-id-type="doi">10.1038/tp.2013.132</pub-id><pub-id pub-id-type="pmid">24548878</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moloney</surname><given-names>RD</given-names></name><name><surname>Desbonnet</surname><given-names>L</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>The microbiome: stress, health and disease</article-title>. <source/>Mamm Genome (<year>2014</year>) <volume>25</volume>(<issue>1–2</issue>):<fpage>49</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1007/s00335-013-9488-5</pub-id><pub-id pub-id-type="pmid">24281320</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prenderville</surname><given-names>JA</given-names></name><name><surname>Kennedy</surname><given-names>PJ</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>. <article-title>Adding fuel to the fire: the impact of stress on the ageing brain</article-title>. <source/>Trends Neurosci (<year>2015</year>) <volume>38</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1016/j.tins.2014.11.001</pub-id><pub-id pub-id-type="pmid">25705750</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Kubera</surname><given-names>M</given-names></name><name><surname>Leunis</surname><given-names>JC</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name></person-group>. <article-title>Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut</article-title>. <source/>J Affect Disord (<year>2012</year>) <volume>141</volume>(<issue>1</issue>):<fpage>55</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.jad.2012.02.023</pub-id><pub-id pub-id-type="pmid">22410503</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Kubera</surname><given-names>M</given-names></name><name><surname>Leunis</surname><given-names>JC</given-names></name></person-group>. <article-title>The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression</article-title>. <source/>Neuro Endocrinol Lett (<year>2008</year>) <volume>29</volume>(<issue>1</issue>):<fpage>117</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">18283240</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zonis</surname><given-names>S</given-names></name><name><surname>Pechnick</surname><given-names>RN</given-names></name><name><surname>Ljubimov</surname><given-names>VA</given-names></name><name><surname>Mahgerefteh</surname><given-names>M</given-names></name><name><surname>Wawrowsky</surname><given-names>K</given-names></name><name><surname>Michelsen</surname><given-names>KS</given-names></name><etal></etal></person-group>
<article-title>Chronic intestinal inflammation alters hippocampal neurogenesis</article-title>. <source/>J Neuroinflammation (<year>2015</year>) <volume>12</volume>:<fpage>65</fpage>.<pub-id pub-id-type="doi">10.1186/s12974-015-0281-0</pub-id><pub-id pub-id-type="pmid">25889852</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Villegas</surname><given-names>A</given-names></name><name><surname>Toledo</surname><given-names>E</given-names></name><name><surname>de Irala</surname><given-names>J</given-names></name><name><surname>Ruiz-Canela</surname><given-names>M</given-names></name><name><surname>Pla-Vidal</surname><given-names>J</given-names></name><name><surname>Martinez-Gonzalez</surname><given-names>MA</given-names></name></person-group>. <article-title>Fast-food and commercial baked goods consumption and the risk of depression</article-title>. <source/>Public Health Nutr (<year>2012</year>) <volume>15</volume>(<issue>3</issue>):<fpage>424</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1017/S1368980011001856</pub-id><pub-id pub-id-type="pmid">21835082</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacka</surname><given-names>FN</given-names></name><name><surname>Cherbuin</surname><given-names>N</given-names></name><name><surname>Anstey</surname><given-names>KJ</given-names></name><name><surname>Butterworth</surname><given-names>P</given-names></name></person-group>. <article-title>Dietary patterns and depressive symptoms over time: examining the relationships with socioeconomic position, health behaviours and cardiovascular risk</article-title>. <source/>PLoS One (<year>2014</year>) <volume>9</volume>(<issue>1</issue>):<fpage>e87657</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0087657</pub-id><pub-id pub-id-type="pmid">24489946</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logan</surname><given-names>AC</given-names></name><name><surname>Katzman</surname><given-names>M</given-names></name></person-group>. <article-title>Major depressive disorder: probiotics may be an adjuvant therapy</article-title>. <source/>Med Hypotheses (<year>2005</year>) <volume>64</volume>(<issue>3</issue>):<fpage>533</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.mehy.2004.08.019</pub-id><pub-id pub-id-type="pmid">15617861</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costello</surname><given-names>EK</given-names></name><name><surname>Stagaman</surname><given-names>K</given-names></name><name><surname>Dethlefsen</surname><given-names>L</given-names></name><name><surname>Bohannan</surname><given-names>BJ</given-names></name><name><surname>Relman</surname><given-names>DA</given-names></name></person-group>. <article-title>The application of ecological theory toward an understanding of the human microbiome</article-title>. <source/>Science (<year>2012</year>) <volume>336</volume>(<issue>6086</issue>):<fpage>1255</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1126/science.1224203</pub-id><pub-id pub-id-type="pmid">22674335</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fond</surname><given-names>G</given-names></name><name><surname>Hamdani</surname><given-names>N</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name><name><surname>Boukouaci</surname><given-names>W</given-names></name><name><surname>Drancourt</surname><given-names>N</given-names></name><name><surname>Dargel</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Effectiveness and tolerance of anti-inflammatory drugs’ add-on therapy in major mental disorders: a systematic qualitative review</article-title>. <source/>Acta Psychiatr Scand (<year>2014</year>) <volume>129</volume>(<issue>3</issue>):<fpage>163</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="doi">10.1111/acps.12211</pub-id><pub-id pub-id-type="pmid">24215721</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenblat</surname><given-names>JD</given-names></name><name><surname>Kakar</surname><given-names>R</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name><name><surname>Kessing</surname><given-names>LV</given-names></name><name><surname>Vinberg</surname><given-names>M</given-names></name><name><surname>Baune</surname><given-names>BT</given-names></name><etal></etal></person-group>
<article-title>Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis</article-title>. <source/>Bipolar Disord (<year>2016</year>) <volume>18</volume>(<issue>2</issue>):<fpage>89</fpage>–<lpage>101</lpage>.<pub-id pub-id-type="doi">10.1111/bdi.12373</pub-id><pub-id pub-id-type="pmid">26990051</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>FM</given-names></name><name><surname>Kirkby</surname><given-names>KC</given-names></name><name><surname>Lichtblau</surname><given-names>N</given-names></name></person-group>. <article-title>Inflammation and immune regulation as potential drug targets in antidepressant treatment</article-title>. <source/>Curr Neuropharmacol (<year>2016</year>) <volume>14</volume>(<issue>7</issue>):<fpage>674</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="doi">10.2174/1570159X14666160115130414</pub-id><pub-id pub-id-type="pmid">26769225</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wegener</surname><given-names>G</given-names></name></person-group>
<article-title>’Let food be thy medicine, and medicine be thy food’: hippocrates revisited</article-title>. <source/>Acta Neuropsychiatr (<year>2014</year>) <volume>26</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1017/neu.2014.3</pub-id><pub-id pub-id-type="pmid">25279413</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Izard</surname><given-names>J</given-names></name><name><surname>Walsh</surname><given-names>E</given-names></name><name><surname>Batich</surname><given-names>K</given-names></name><name><surname>Chongsathidkiet</surname><given-names>P</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>The host microbiome regulates and maintains human health: a primer and perspective for non-microbiologists</article-title>. <source/>Cancer Res (<year>2017</year>) <volume>77</volume>(<issue>8</issue>):<fpage>1783</fpage>–<lpage>812</lpage>.<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-16-2929</pub-id><pub-id pub-id-type="pmid">28292977</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhasselt</surname><given-names>V</given-names></name></person-group>. <article-title>Neonatal tolerance under breastfeeding influence</article-title>. <source/>Curr Opin Immunol (<year>2010</year>) <volume>22</volume>(<issue>5</issue>):<fpage>623</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1016/j.coi.2010.08.008</pub-id><pub-id pub-id-type="pmid">20851590</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez-Bello</surname><given-names>MG</given-names></name><name><surname>Costello</surname><given-names>EK</given-names></name><name><surname>Contreras</surname><given-names>M</given-names></name><name><surname>Magris</surname><given-names>M</given-names></name><name><surname>Hidalgo</surname><given-names>G</given-names></name><name><surname>Fierer</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2010</year>) <volume>107</volume>(<issue>26</issue>):<fpage>11971</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1002601107</pub-id><pub-id pub-id-type="pmid">20566857</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biasucci</surname><given-names>G</given-names></name><name><surname>Rubini</surname><given-names>M</given-names></name><name><surname>Riboni</surname><given-names>S</given-names></name><name><surname>Morelli</surname><given-names>L</given-names></name><name><surname>Bessi</surname><given-names>E</given-names></name><name><surname>Retetangos</surname><given-names>C</given-names></name></person-group>
<article-title>Mode of delivery affects the bacterial community in the newborn gut</article-title>. <source/>Early Hum Dev (<year>2010</year>) <volume>86</volume>(<issue>Suppl 1</issue>):<fpage>13</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.earlhumdev.2010.01.004</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117</label>
<mixed-citation publication-type="webpage">Available from: <uri xlink:href="http://www.human-microbiome.org/" xlink:type="simple">http://www.human-microbiome.org/</uri> [accessed on 05.30.2017].</mixed-citation>
</ref>
<ref id="B118">
<label>118</label>
<mixed-citation publication-type="webpage">Available from: <uri xlink:href="http://eldermet.ucc.ie/" xlink:type="simple">http://eldermet.ucc.ie/</uri> [accessed on 05.30.2017].</mixed-citation>
</ref>
<ref id="B119">
<label>119</label>
<mixed-citation publication-type="webpage">Available from: <uri xlink:href="http://www.optimd.de/" xlink:type="simple">http://www.optimd.de/</uri> [accessed on 05.30.2017].</mixed-citation>
</ref>
<ref id="B120">
<label>120</label>
<mixed-citation publication-type="webpage">Available from: <uri xlink:href="http://www.metahit.eu/" xlink:type="simple">http://www.metahit.eu/</uri> [accessed on 05.30.2017].</mixed-citation>
</ref>
<ref id="B121">
<label>121</label>
<mixed-citation publication-type="webpage">Available from: <uri xlink:href="http://www.hmpdacc.org" xlink:type="simple">http://www.hmpdacc.org</uri> [accessed on 05.30.2017].</mixed-citation>
</ref>
<ref id="B122">
<label>122</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>O’Mahony</surname><given-names>S</given-names></name></person-group>. <article-title>The microbiome-gut-brain axis: from bowel to behavior</article-title>. <source/>Neurogastroenterol Motil (<year>2011</year>) <volume>23</volume>(<issue>3</issue>):<fpage>187</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2982.2010.01664.x</pub-id><pub-id pub-id-type="pmid">21303428</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>